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RESUMO 
 
O óxido nítrico (NO) está envolvido em muitos processos biológicos e sua 
liberação na interface biomaterial/tecido tem mostrado diminuir a inflamação, 
estimular a proliferação celular e inibir a adesão plaquetária. Portanto, o 
revestimento de dispositivos médicos implantáveis com polímeros liberadores de NO 
pode melhorar significativamente a biocompatibilidade e a integração tecidual. Neste 
projeto é descrito o desenvolvimento de revestimentos poliméricos degradáveis com 
capacidade de fornecer NO durante períodos prolongados (˃ 1 mês). O biomaterial 
foi constituído por uma matriz de poli(ácido L-láctico)(PLLA, Mw 3,582 g mol
-1) 
impregnada com o doador de NO S-nitroso-N-acetil-D-penicilamina (SNAP). O 
método de spin coating foi usado para obter revestimento de mono e bicamadas 
partindo de soluções de PLLA-SNAP dissolvidas em tetrahidrofurano e depositadas 
na superfície de substratos de polipropileno. Com o fim de melhorar a hidrofilicidade 
do material, o PLLA foi blindado com poli(óxido de etileno)(PEO, Mv 400,000 g mol
-1) 
através de moldagem por evaporação de solvente. Caracterizações térmicas das 
blendas PLLA/PEO foram realizadas para investigar a miscibilidade dos polímeros. A 
cinética em tempo real da liberação de NO dos materiais foi analisada durante uma 
hora sob condições fisiológicas (pH 7.4, 37 ºC) por quimiluminescência. Os 
revestimentos apresentaram uma taxa de liberação na faixa de 6 - 20 pmol cm-2 min-
1, menor que a produção endógena de NO. A degradação hidrolítica dos 
revestimentos carregados com SNAP foi caracterizada sob condições fisiológicas e 
aceleradas (pH 9, 60 ºC). Revestimentos de mono e bicamada mostraram uma 
liberação inicial de NO rápida acima de 7 h. Depois de 30 dias de degradação 
hidrolítica sob condições aceleradas a liberação total de NO de monocamadas com 
10 % e 20 % (m/m) de SNAP foi de 28.7 ± 0.2 nmol cm-2 e 67.0 ± 0.2 nmol cm-2, 
respetivamente. No caso de bicamadas, a liberação de NO foi prolongada por mais 
13 dias. Por fim, o uso de uma segunda camada de PLLA puro reduziu 
significativamente a liberação de NO, a qual se encontra na faixa de 2.5 - 3.2 nmol 
cm-2 que se prolongou por 72 dias. Em resumo, os revestimentos de PLLA-SNAP 
são capazes de manter uma liberação de NO por períodos prolongados sob 
condições fisiológicas. 
 
 
 
 
 
 
ABSTRACT 
 
Nitric oxide (NO) is involved in several biological processes and its release 
at biomaterial/tissue interface has been shown to decrease inflammation, stimulate 
cells proliferation and inhibit platelet adhesion. Therefore, the coating of implantable 
medical devices with NO-releasing polymers may significantly improve 
biocompatibility and tissue integration. Herein, we describe the development of 
biodegradable polyester coatings which are capable of delivering NO for prolonged 
periods (˃ 1 month). The biomaterial was comprised of a poly(L-lactic acid) (PLLA, 
Mw 3,582 g mol
-1) matrix impregnated with the NO donor S-nitroso-N-acetyl-D-
penicillamine (SNAP). The spin coating technique was used to obtain mono and 
bilayer coatings of PLLA-SNAP solutions dissolved in tetrahydrofuran and deposited 
on top of polypropylene substrates. Poly(ethylene oxide)(PEO, Mv 400,000 g mol
-1) 
was blended with the PLLA matrix by solvent casting to improve the material´s 
hydrophilicity by solvent casting. PLLA/PEO blend thermal characterizations was 
performed in order to investigate the polymers miscibility. The real-time kinetics of 
NO released by the materials were analyzed during one hour under physiological 
conditions (pH 7.4, 37 ºC) by chemiluminescence. NO release rates were in the 6 to 
20 pmol cm-2 min-1 range, which is lower than the rate of endogenous NO production. 
The hydrolytic degradation of the SNAP-doped coatings was characterized under 
physiological and accelerated (pH 9, 60 ºC) conditions; Monolayer and bilayer 
coatings showed an initial fast NO release profile up to 7 h at pH 7.4, 37 ºC. In 30-
day experiments under accelerated conditions, the total NO release from SNAP 10 wt% 
and 20 wt% monolayers were, respectively, 28.7 ± 0.2 nmol cm-2 and 67.0 ± 0.2 nmol 
cm-2 . In the case of bilayer coatings, NO release duration was prolonged by 13 days. 
Finally, the use of a PLLA topcoat reduced significantly the cumulative NO release, 
which lasted over 72 days and was found to be in the 2.5 to 3.2 nmol cm-2 range. In 
summary, PLLA-SNAP coatings are capable of sustaining NO release over long 
periods under physiological conditions. 
 
 
 
 
 
 
 
 
RESUMEN 
 
El óxido nítrico (NO) está relacionado a muchos procesos biológicos y su 
liberación en la interface biomaterial/tejido ha demostrado disminuir la inflamación, la 
estimulación de proliferación celular y la inhibición de adhesión plaquetaria. Por lo 
tanto, el revestimiento de dispositivos médicos con polímeros liberadores de NO 
podría mejorar significativamente la biocompatibilidad y la integración tisular. En el 
presente proyecto se describe la elaboración de revestimientos poliméricos 
biodegradables con capacidad de liberar NO durante tiempos prolongados (> 1 mes). 
El biomaterial fue constituido por una matriz polimérica de poli(ácido L-lático) )(PLLA, 
Mw 3,582 g mol
-1)  impregnado con un donador de NO S-nitroso-N-acetil-D-
penicilamina (SNAP). Revestimientos de mono y bicapa fueron fabricados mediante 
el método spin coating, usando soluciones poliméricas de PLLA-SNAP disueltas en 
tetrahidrofurano, las cuales fueron depositadas sobre la superficie de polipropileno 
usado como substrato. Con el objeto de mejorar la hidrofilicidad del material, 
mezclas poliméricas fueron obtenidas  por solvent casting a partir de PLLA e con 
poli(óxido de etileno)(PEO, Mv 400,000 g mol
-1) comercial. La mezcla polimérica 
PLLA/PEO fue caracterizadas térmicamente para investigar la miscibilidad. La 
cinética en tiempo real de la liberación de NO de los revestimientos fue analizada 
durante una hora en condiciones fisiológicas (pH 7.4, 37 ºC) por quimioluminiscencia. 
Los revestimientos  exhibieron una tasa de liberación en un rango de 6 - 20 pmol cm-
2 min-1, menor que la producción de NO endógena. La degradación hidrolítica de los 
revestimientos cargados con SNAP fue realizada en condiciones fisiológicas y 
aceleradas (pH 9, 60 ºC). Muestras de mono y bicapas exhibieron una liberación 
rápida inicial de NO después de 7 h. Después de 30 días de degradación hidrolítica 
en condiciones aceleradas la liberación total de NO de una monocapa con  10 % e 
20 % (m/m) de SNAP fueron 28.7 ± 0.2 nmol cm-2 e 67.0 ± 0.2 nmol cm-2, 
respectivamente. En el caso de la bicapa, la liberación de NO fue prolongada 13 
días más. Finalmente, la aplicación de una segunda capa de PLLA puro redujo 
significativamente la liberación de NO entre 2.5 - 3.2 nmol cm-2 después de 72 días 
de degradación. En síntesis, los revestimientos de PLLA-SNAP demostrar poseer la 
capacidad de mantener una liberación de NO a lo largo de periodos extendidos en 
condiciones fisiológicas. 
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1. INTRODUCTION 
 
The in vivo performance of biomaterials is mainly determined by their 
biocompatibility with the biological system they are designed for. Increasing 
biocompatibility especially of implantable devices is one of the major challenges 
involved in the development of biomaterials since some of these devices have 
thrombogenic surfaces that lead to serious clinical complications. Incorporating 
compounds in the biomaterial matrix with specific features intended to improve the 
tissue/biomaterial compatibility is a widely used approach to tackle this problem. 
Nitric oxide (NO) is an endogenously synthesized molecule, with key roles in many 
important cellular processes.1-3 Due to such functions, the use of exogenous NO 
donor molecules for improving biocompatibility have been largely explored in the last 
few decades.4-6 In recent years, most of the research concerning NO-releasing 
biomaterials comprising in vivo and in vitro studies highlight the therapeutic potential 
of NO-releasing biomaterials. 
 
1.1. Nitric Oxide 
1.1.1. NO Chemistry and physical chemistry properties 
 
Nitric oxide (according to IUPAC) is a colorless gas at standard state.7,8 
This little molecule reacts with oxygen to form brown nitrogen dioxide and do not 
react with water.7-9 It has a small dipole moment resulting in a low solubility in water 
(1.95 mM atm-1 at 25°C).10 NO has a melting point of –163 °C, boiling point of –
151.7 °C, and liquid density of 1.269 (at boiling point).7 Since the discovery of NO in 
the 1980s as an important physiological regulator,11 its biochemistry has been widely 
studied and established, and led to its selection as “the molecule of the year” in 1992 
by the journal Science.  
 
NO is a free radical with an odd valence electron in an anti-bonding π* 
molecular orbital (HOMO), as can be seen in the molecular orbital diagram of Fig.1,12 
which suggests a high reactivity as a carbon-center radicals.A This is not the case for 
NO, it is a stable free radical. For instance, it does not dimerize in the gas phase or 
solution under normal conditions at room temperature through the eliminating the 
unpaired electron; this single electron does not have preference to be centered on 
the nitrogen nor oxygen atom, it is delocalized between both atoms.9,A Its valence 
bond representation is also shown in Fig.1. There are two possible resonance 
structures, both with a double bond with a bond order of 2.5, the bond length of 1.154 
16 
 
Å, which is found between a bond length of a double (1.18 Å) and a triple (1.06 Å) 
bond.14  
 
Fig. 1. Left molecular orbital diagram of NO showing the unpaired electron in an anti-
bonding π* molecular orbital. Right NO valence bond representation showing the two 
resonance structures.  
 
Even though NO is a stable radical, it reacts with other paramagnetic 
species (superoxide ion O2
- and O2) or metal centers.
8,9 This high reactivity is 
explained its radical nature, an involves its reduction to the nitroxide ion (NO-), 
oxidation to the nitrosonium ion (NO+), reaction with oxygen (yielding NO2) and 
reaction with halogens.7,14 The different redox forms undergo bond length changes; 
in the oxidation to NO+, the bond length is reduced to 1.06 Å (bond order 3),while in 
its reduction to NO-, the bond length increases to 1.26 Å, because of the gain of one 
electron in the π* molecular orbital.15,16 The infrared stretching frequencies (vNO) are 
from 2377 cm-1 for NO+, 1875 cm-1 for NO and 1470 cm-1 for NO-.17  
 
The reaction of NO with oxygen in water is well studied but the mechanism 
is still uncertain. The reactions involve the formation of NO2 (Eq.1), reacts with NO to 
give N2O3 (nitrous acid anhydride) (Eq.2). Afterwards N2O3 hydrolyses to yield NO2¯ 
(Eq.3). If the NO2 concentration is not enough for dimerization to form N2O4, no 
significant quantities of NO3¯ can be produced (Eq.4).
18,19 The concentration of nitrite 
and nitrate are used as markers for in vitro and in vivo NO.18 
 
                                                   (1) 
N 
Atomic Orbitals 
O 
Atomic Orbitals 
𝝈𝟐
∗  
𝝈𝟏
∗  
𝝅∗ 
𝝅 
𝝈𝟐 
𝝈𝟏 
2p 
2p 
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                                                     (2) 
               
                                (3) 
            
     
      ............................(4) 
 
For overall NO oxidation reaction (Eq.5), the rate law for the oxidation of 
NO is second order relative to NO and first order relative to O2 (Eq.6). The rate 
constant, kaq is reported as 9 x 10
6 M-2 s-1, at 23 ºC.9,20  
 
                
                                 (5) 
 
     
  
         
                                      (6) 
 
The NO behavior in water is much simpler than in the biological 
environment. The biological activity of NO is complex; it reacts in the cellular 
environment to give a variety of products with different biological effects.9 Its high 
solubility in membranes or hydrophobic environment accelerates the rate of NO 
oxidation by a factor of about 300 and its reacts with radical species eliminating 
dangerous radical species from biological systems.8,21 In conclusion, features such 
as the small size, the lipophilicity and the high diffusion rate are important factors in 
the biological role of NO. 
 
1.1.2. Nitric oxide biological syntheses  
 
Endogenous NO is produced by most cell types by the aerobic oxidation of 
one the terminal guanidino nitrogen atoms of L-arginine (Arg) to L-citrulline, catalyzed 
by nitric oxide synthases (NOSs) (Fig.2).22 In the first step, Arg is hydroxylated to N-
hydroxy-L-arginine (NHA), where 1 mol of NADPH (nicotinamide adenine dinucleotide 
phosphate, reduced form) and O2 are consumed. Afterwards, NHA is oxidized to L-
citrulline with the consumption of 0.5 mol of NADPH and 1 mol of O2, yielding NO and 
1.5 mol of NADP+ (oxidized nicotinamide adenine dinucleotide phosphate).Once NO 
is produced, it diffuses until reaching the target cells.23 
 
In mammals, three distinct isoforms of NOS have been identified: neuronal 
nNOS, inducible iNOS and endothelial eNOS types.22 Each one is associated with a 
k1 
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particular physiological process. The constitutive isoforms (nNOS and eNOS) are 
Ca2+ dependent and required calmodulin, a calcium sensor. On the other hand, the 
inducible isoform (iNOS) is Ca2+ independent (Ca2+ and calmodulin are already bond) 
and produces larger NO amounts (˃ µM).8 Constitutive nNOS or NOS I is involved in 
the neurotransmission process; iNOS or NOS II act as a cytotoxic agent in normal 
immune defense against microorganisms and tumor cells; finally, constitutive eNOS 
or NOS III regulate smooth muscle relaxation and blood pressure.23 
 
Fig. 2. Endogenous synthesis of nitric oxide from the oxidation of arginine into 
citrulline in the presence of the cofactor NADPH.23 
 
1.1.3. Physiological NO actions 
 
NO takes part in several cellular processes, to mention some, the 
vasodilation, the inhibition of platelet adhesion, thrombosis prevention,24 the 
promotion of endothelial proliferation, re-epithelialization and collagen production in 
the wound healing process;25  the reduction of bacterial adhesion26 as well as 
stimulate blood flow increase (vasodilation),27 which is related to many biological 
responses such as female sexual dysfunction.28 
 
The most interesting NO participation in the cellular process for the aim in 
this project is the physiological action of NO in the vascular vessel. In situ, endothelial 
cells continuously produce low amounts of NO as the principal physiological source 
of NO in the vascular system by the eNOS constitutive isoform as was 
aforementioned (  2 nM).8,29,30 The NO produced controls the blood flow, which is 
the most important function, supplying indirectly oxygen to organs and governing the 
blood cell interaction with the vascular wall.31 The production of this constitutive NO 
is known as basal production which is modulated when the endothelial cells suffer 
19 
 
shear stress, which stimulates the expression of NO synthase.32,33 Fig.3 shows the 
biological actions of NO occurring at physiological levels; the cytoprotection against 
ischemia (lack of blood) and the regulation of blood flow to tissues:8 NO enhances 
the development of blood vessel (angiogenesis) as a response of ischemia in tissues. 
In the cell, NO also attenuates mitochondrial respiration, programmed cell death 
(apoptosis), as well as the antioxidant function as mentioned before. Additionally, NO 
promotes vasodilation and inhibits both platelet and leukocyte aggregation. In 
summary, all these effects maintain blood homeostasis.8 
 
 
 
Fig. 3. Biological action of NO in the vascular vessel depicting the vasodilatation and 
antioxidant effect; the role in the mitochondrial respiration, cellular apoptosis and 
mitochondrial biogenesis. Reproduced with permission.8 Copyright 2010, Elselvier  
 
Novel potential therapeutic application of NO has been explored, such as 
anti-cancer since NO may act as a cytotoxic species against tumor cells leading to 
apoptosis.34,35 Additionally, an antiviral action of NO is proposed and studied as well, 
due to it can pass through the cells, acting as a defense mechanism before the 
development of a specific immune response.23 
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1.2. S-nitrosothiols (RSNOs) as NO donors 
1.2.1. NO release from RSNO 
 
A compound can be classified as NO donor when its chemical structure 
has a functional moiety which can generate NO. Each class of NO donors has 
structural differences leading to large range of chemical relativities conferring 
advantages and disadvantages related to the NO release triggering and delivery 
system.36 Basically, there are three NO release mechanisms; the first one is the 
spontaneous NO release, by means of thermal or photochemical self-decomposition 
of compounds such as N-diazeniumdiolates (NONOates) and S-nitrosothiols 
(RSNOs); the second mechanism comprises chemical reactions with other species 
and the last one is the enzymatic oxidation.23 
 
1.2.2. RSNO chemistry, biochemical function and some applications 
 
It has been demonstrated in several studies that RSNOs represent a 
source of endogenous NO, and have better biocompatibility compared to NONOates 
as exogenous NO donors. 37 Nevertheless, RSNOs are not yet approved for clinical 
practice.37 Fig.4 shows the generic thio-ester structure of tionitrite highlighting the 
sulfur-nitrogen bond, which is a stable covalent bond, slightly polar which may be 
easily synthesized through the S-nitrosation of the parent thiol (RSH).38 The most 
common nitrosation method involves reacting thiols with the nitrosonium ion (NO+) in 
a highly acidic environment.39,40 NO+ is generated by the conversion of NO2
— added 
as a sodium nitrite. RSNOs have two configurational isomers which have been 
computational studied, analyzing HSNO and CH3SNO configuration and calculating 
the bond lengths of the lowest energy conformation for trans and cis configuration.23 
 
 
Fig. 4. RSNO configurational isomers and computational calculated bond lengths. 
Left trans HSNO configuration. Right cis CH3SNO configuration.
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The chemical nature of the R group, heat as well as light influence the 
thio-ester formation and stability. A bulky protecting group confers stability making 
difficult the nucleophile attack. For instance the thionitrite derivatives of N-
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acetylpenicillamine (NAP) and t-butyl-thionitrite are compounds that have steric 
hindrance.41,42 Pure solid SNAP has shown to be a stable solid which decomposes 
above 150 °C releasing NO.18,41 Additionally, RSNOs solutions are sensitive to 
catalytic decomposition by copper ions that may be present in the solution.40,43,44 Also 
RSNOs solutions undergo acid catalyzed hydrolysis (Eq.7) or heterolytic fission in the 
alkaline pH case as shown in Eq.8. Therefore, such factors must be taken into 
account to guarantee RSNO stability in the polymeric matrix. 
 
                                                  (7) 
             
                                      (8) 
 
The RSNOs typical ultraviolet absorption peaks are found approximately at 
200 nm, 335 nm, 500 nm and 550 nm with molar absortivities equal to 10,000, 1,000, 
5 and 5 M-1 cm-1, respectively.42,45 RSNOs infrared analysis are given NO stretching 
values around 1490 to 1700 cm-1 and bending frequencies around 610-660 cm-1.42,46 
For 16N-NMR RSNOs spectra analysis, there are shifts in comparison with NaNO2 
spectrum (587 ppm) in the 750-790 ppm range.47 In respect to the RSNO 
quantification, there are fluorescence methods (using dyes) and the Saville reaction 
(nitrosyl replacement by mercury of the thiol group).7 Nevertheless, these methods 
are not sensitive enough to measure the RSNOs physiological levels (nM range, or 
pM range). Undeniably, the chemiluminescence method using Sievers NOATM 280i 
instrument is one of the most sensitive to quantify low NO concentrations cleaving 
the linkage between sulfur and NO.7 
 
Although RSNOs do not spontaneously release NO, this process can be 
triggered by different approaches such as the catalytic decomposition using transition 
metals (Cu+ ions), the direct reactions with ascorbate salts, heat and light. In the 
latter cases, NO release is a result of the homolytic cleavage of the S–NO bond, 
which leads to the formation of thiyl radicals (Eq.9). These radicals can recombine 
leading to the formation of the RS-SR dimer (Eq.11), or may react with a second S-
NO group, leading to the formation of a sulfur bridge with simultaneous release of a 
second NO molecule (Eq.10).36,39,40,43 
 
                                                     (9) 
                                                        (10) 
hv  
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                                                         (11) 
 
In biological systems, RSNOs have been identified in nanomolar 
concentrations in cells and body fluids.7,27 In the case of vascular vessel, the surface 
flux rate by healthy endothelial cells from the inner walls of the blood stream, has 
been reported as 5 - 40 nmol cm-2 min-1.48-50 For instance, low molecular weight RS-
NOs was identified in the plasma of human subjects treated with nitroglycerin;51 S-
nitroso-glutathione (GSNO) has been identified as well in concentrations sufficient to 
influence basal brachial tone.52 RSNOs have shown biological actions such as 
antimicrobial actions and inherently possess the aforementioned NO biological 
action.27  
 
The antimicrobial action of NO was associated with the covalent 
modification of bacterial membrane sulfhydryl groups by the thiyl group inductive 
effect which is independent of the spontaneous NO release.53,54 Also, this 
antimicrobial action comprehends a chemical alteration of DNA, due to the reaction of 
NO with superoxides to form nitrogen and oxygen intermediates, which induce the 
DNA alterations such as nitrosylation of nuclei acids, avoiding the DNA replication of 
bacteria.55,56 Additionally, this antimicrobial action was shown to be independent of 
RSNOs size, shape, charge, hydrophobicity and membrane permeability.27 
 
The incorporation of RSNO groups into polymeric matrices, includes the 
use of SNAP (Fig.5a), which is a hydrophobic NO donor extensively used in scientific 
research.40,57-64 Its hydrophobic character favors its location in the hydrophobic 
polymer phase.59 For SNAP syntheses, the acid nitrosation of N-acetylpenicillamine 
proposed in 1978 by Field et al has been widely used and barely modified.41 Fig.5b. 
shows the absorption maxima in 341 nm and a second weak absorption in 595 nm.65 
The stability of tertiary RSNO in the face of primary RSNO has been highlighted in 
studies of SNAP-doped polymers, with respect to the loss of NO;60 tertiary RSNO 
stability is conferred by the steric hindrance of the sulfur atom imposed by the methyl 
group. This is important considering that NO-donors in polymeric systems must 
remain stable throughout the entire preparation process, resist storage and release 
NO only during or after the application time. However, this kind of NO donors 
decomposes following the same pathways mentioned before, yielding NO and the 
dimer of NAP. The chelator property of NAP is widely studied and used in treatment 
of heavy metal intoxication, such as mercury poisoning and excessive cupper 
accumulation know as a Wilson´s disease.61-66 Hence, the SNAP decomposition will 
not represent any toxicity risk for materials loaded with SNAP employed for medical 
proposed. 
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Fig. 5(a) SNAP chemical structure showing the tertiary S-nitrosothiol and (b) UV- Vis 
spectra of 1.6 mM SNAP in methanol.65 
 
The loaded SNAP in hydrophobic polymeric matrix has shown to be a 
good strategy to improve the lifetime of NO donors, to administrate NO exogenously 
and simulate the biological NO flux. Meyerhof’s research group have studied the 
SNAP solubility in hydrophobic polymers and found that SNAP barely dissolves 
(solubility: ca. 3.4 - 4.0 wt%), the SNAP excess crystallizes in orthorhombic form, 
contributing to shelf stability and slow dissolution of the crystals due to the hydrogen 
bonding between SNAP molecules, resulting in a long term release under 
physiological conditions.67 Besides, they suggested that the NO release rate from 
SNAP-doped hydrophobic materials is controlled by the total water contacting the 
surface area of the polymer film and depends on the SNAP concentration within the 
film, where NO release rate does not increase as the thickness of the film increases; 
if this area remains the same, the NO release rate decreases as the SNAP 
concentration decreases. Also, the SNAP concentration and the thickness of the film 
determine the long-term NO release.68 Additionally, other studies performed by that 
research group observed that SNAP can be leached out from the film at lower rate 
than the NO release from the polymer, which can be counteracted by the deposition 
of a polymer topcoat.68 
 
Fig.6 shows the representation of the NO release mechanism proposed by 
Yaqi Wo., et al. 67, which describes an interesting theory for SNAP decomposition in 
biomaterials that shows low water uptake (hydrophobic), which is summarized by 
three factors: 1) the SNAP concentration in the polymer matrix; as SNAP crystals 
slowly dissolve into the solid polymer SNAP molecules are released; 2) the polymer 
surface area exposed to the aqueous solution where free SNAP molecules dissolve 
in the aqueous media and decomposes releasing NO; and 3) the film thickness of the 
specific material. These factors lead to long-term NO release, being directly 
proportional to the SNAP loading. In conclusion, SNAP solubilizes in the polymer 
(a) (b) 
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matrix, later, in water-rich regions near the polymer/solution interface, SNAP 
decomposes and releases NO. Additionally, the SNAP crystal dissolution leads to a 
decrease in the dissolution of more crystalline SNAP because the bulk polymeric 
phase becomes saturated. 
 
 
Fig. 6. Schematic representation of NO release mechanism from a hydrophobic 
polymer showing the three determining factors; the SNAP concentration, the water 
contacting surface area and the film thickness. Reproduced with permission.68 
Copyright 2015, American Chemical society. 
 
1.3. NO releasing materials 
 
Biomedical advances have encouraged the development of biodegradable 
platform materials. For instance, regenerative medicine, tissue engineering and 
controlled drug delivery are biomedical technologies that require biomaterial-based 
platforms.69 According to Willians D.F, a biomaterial can be defined as a material 
intended to interface with biological systems to evaluate, treat, augment or replace 
any tissue, organ or function of the body.70 
 
The biodegradability is an important concern for the biomaterial 
applications. Some important properties of a biodegradable biomaterial are sited: 
biologic inertness, non-toxic degradation products; ability to be metabolized and 
cleared from the body; the biomaterial/biological system contact should not evoke 
inflammation or toxic response; the mechanical properties of the material should be 
appropriate for the intended application. Besides, during the biomaterial degradation, 
those mechanical properties should be compatible with the biological process for 
which it was designed. Finally, the degradation time should be enough to accomplish 
the function.71  
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Polymeric materials have a variety of mechanical and degradation 
properties that confer special features for the biomaterial applications. Due to their 
versatility, in some cases they replace other biomaterial, such as metals, alloys and 
ceramics. The material chemistry, the molecular weight, the solubility, the 
hydrophobicity and degradation affect their biocompatibility. Among the biomedical 
applications it is included the controlled drug delivery: the bioactive agents are 
loaded inside the polymeric matrix from which they are released by the erosion or 
diffusion (or both) processes.71 
 
For the NO delivery, several biomaterial-based platforms have been used, 
involving strategies to link NO-donors with delivery systems, acting as a source of 
circulating NO for sustained release (Fig.7); These delivery systems comprehend 
micelles, liposomes, polysaccharides, zeolites, inorganic silica nanoparticles, 
inorganic multifunctional nanoparticles (such as gold particles), self-assembled  
polymeric monolayers and sol-gel coating.36,37 
 
 
Fig. 7. Biomaterial-based platforms strategies for sustained NO delivery. Reproduced 
with permission.37 Copyright 2012, Wiley-VCH. $Reproduced with permission.72 
Copyright 2009, American Chemical society.*Reproduced with permission.73 
Copyright 2010, Elservier. 
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The coating platform strategy can be used for localized delivery by means 
of adsorption. NO donors can be blended with polymers and afterwards adhered 
physically to the surface of a substrate using dip-coating, spin-coating or spray 
coating techniques.74,75 In particular, spin coating represents an excellent strategy to 
obtain high-quality multilayer thin coatings on different substrates, when using 
polymeric solutions with volatile solvents. This technique can be divided into four 
steps: 1) solution deposition, in which the liquid is dropped on the substrate held by a 
disk which is rotating at a low rotating speed, so that the liquid can flow over until the 
edge of the disk; 2) spin-up, in which the disk rotating speed is accelerated to a set 
speed, ω, and the liquid flows radially, due to centrifugal force, covering the whole 
substrate area; 3) spin-off, in which the excess liquid flies off the edges, and a thin 
uniform liquid film is formed under the constant rotating speed; and 4) film drying, in 
which the liquid solidifies due to the solvent evaporation.76 This technique was used 
in this project to coat model surfaces of polypropylene. 
 
Meyerhoff and coworkers have been explored a varieties of strategies to 
load materials with NO donors and have been characterized the NO release profiles 
for the obtained NO release biomaterials doped with SNAP, as well as biological 
assays to evaluated the potential as biomaterial. Among the polymeric materials, 
polyurethane (Carbosil® 20 80A) films doped with SNAP were analyzed and 
demonstrated to be effective to control the bacterial adhesion and microbial infection 
on the material surface, due to the synergistic effect of physical topographic surface 
modification and the NO action, that decreased the available surface area, while the 
decomposition of SNAP within polymer film initiated the NO release at flux levels 
higher than 50 nmol min-1cm-2 up to 10 days. 77,78  
 
On the other hand, the stability of SNAP within the polymer is other 
important matter in NO releasing materials. For instance coatings of E2As polymer 
load with SNAP exhibited an excellent storage stability, after 2 months storage at 
37 °C 82% of the initial SNAP was retained.59 The same platforms strategy was 
tackled for sustained NO delivery by catalytic decomposition of SNAP in blood, via 
copper mechanism, using NO generating material polymeric coating, composed of 
copper nanoparticle-containing polyurethane combined with systemic SNAP 
administration (0.1182 mmol/kg/min), after 4 h of blood exposure, the extracorporeal 
circulation circuits in a rabbit thrombogenicity model yielded significantly reduced of 
thrombus formation and platelet aggregation.79 The same catalytic decomposition 
(copper ions mechanism) was used in studies of tunable NO release from Carbosil 
coatings with top-coated polymer composites with copper nanoparticles, which 
increased the NO release flux from 132 nmol min-1 cm-2 to 448 and 1170 nmol min-1 
cm- with 1 and 5 wt % copper nanoparticles; increased the antimicrobial activity and 
decreased the platelet adhesion.80 
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Studies related to poly(lactic acid) (PLA) matrix doped with SNAP were 
realized by the Meyerhoff´s group. They encapsulated the SNAP within poly(lactic-
co-glycolic acid) 50:50 (PLGA) microspheres to sustain NO release (ca 0.56 µmol 
SNAP/mg microspheres.), which was governed by the erosion of PLGA  
microspheres. They observed that using the ester capped PLGA (Mw = 38,000–
54,000) the NO released was prolonged for over 4 weeks. Additionally, they analyzed 
the different catalytic decomposition to obtain sustained NO release such as copper 
ions and/or ascorbate salts and light.57 
 
Other reported strategy such as silica has been studied as system for NO 
releasing materials at controlled rates, especially as particles, which are covalently 
attached with NAP and by reaction with t-butylnitrite, tertiary RSNO-modified 
materials are obtained.60,80,82 The incorporation of SNAP-fumed silica in polymeric 
materials shown maintained NO release and possessed biological potential such as 
antimicrobial activity, inhibition of bacteria adhesion. For instance, the system of 
SNAP-fumed silica particles (21–138 nmol/mg) were blended with polyurethane to 
create films and generated NO fluxes of approximately of 750 nmol cm-2 min-1 
catalyzed by copper ions. Contrary to the silicone rubber films, which only liberated 
NO by photolytic decomposition.82 
 
1.3.1. Poly(lactic acid) 
 
Polymeric matrices may exert an important effect on the kinetics of NO 
release. Several studies report the use of hydrophobic aliphatic polyesters such as 
poly(glycolic acid), poly(vinyl chloride), poly(caprolactone) and poly(lactic acid) (PLA) 
among others as matrices for the incorporation of NO donors.83-86 PLA, in special, is 
considered a versatile biodegradable polymer, which is degraded by simple 
hydrolysis generating non-toxic byproducts, which are eliminated through normal 
cellular activity. The chemical properties and characteristics of PLLA will be cited in 
the subsequent sections, especially, the factors that contribute with the PLLA 
degradation. 
 
1.3.1.1. PLLA chemical properties 
 
PLA is a thermoplastic polymer constituted by aliphatic ester linkages in 
their backbone.71 PLA or polylactide has a structural variety (Fig.8) due to its 
monomer, the lactic acid (LA), which has a chiral carbon, resulting in configurational 
isomers consisting of enantiomeric D- and L-lactic acid units in different sequences 
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and ratios. Enantiomeric polymers are commonly called PLLA and poly(D-lactic acid) 
(PDLA). While a racemic polymer consisting of a random sequence of both 
enantiomeric units is called poly(DL-lactic acid) (PDLLA).71,87  
 
Fig. 8. Structural formula of PLLA. The asterisk shows the chiral carbon. 
 
Basically, PLA can be synthetized by two routes according to Fig.9:87 
direct polycondensation (PC) of LA by the elimination of water (byproduct), in the 
presence of single (metal-compound) or binary (metal compounds activated with 
proton acids) catalysts.88,89 The challenge to obtain high molecular weight PLA is to 
drive the dehydration equilibrium in the direction of esterification by using an organic 
solvent.69 For instance, there is a PLA synthetic method, in which water/xylene 
azeotropic mixture is collected using a Dean Stark trap. The other route is the ring 
opening polymerization (ROP) of cyclic diester of LA, known as lactide, obtained 
through dimerization of LA catalyzed by metal-based or organic compounds.87 The 
polymerization can be performed through cationic, anionic, coordination or free 
radical polymerization.69,90 
 
However, these common routes have disadvantages. In the PC, the 
azeotropic distillation of solvent used, the complete removal of solvent and the 
difficulty in driving the dehydration equilibrium to the direction of esterification are 
some of the challenges to deal with.69 On the other hand, the ROP route requires 
high cost of production due to the demanding purification process of the 
lactide.69,88,89,91 For that reason, alternative synthetic routes have been suggested 
such as melt polycondensation followed by solid-state polycondensation, offering 
high molecular weight PLA with high yield in comparison to the ROP route.69 
 
PLLA is a semicrystalline, slow-degrading polymer, with good tensile 
strength and a high modulus of approximately 4.8 GPa. The crystallinity degree 
depends on the molecular weight and the polymer processing parameters. Its thermal 
properties have been widely studied; the glass transition temperature, Tg has been 
reported in the range of 50 to 65 °C; the melting temperature, Tm has been reported 
as well, ranging from 160 to 180 °C.87,92 The melting enthalpy of 100% crystalline 
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PLLA varies from 82 to 203 J/g and the degradation temperature was estimated at 
around 307 to 310 °C.87,93-95 Additionally, the heat capacity of the solid state, Cpsolid 
below Tg is related to the vibrational motion of the PLLA macromolecule. 
 Conversely, 
the heat capacity of the liquid state Cliquid is associated to the vibrational and 
conformational motions.94 
 
 
 
Fig. 9. PLA synthesis routes (a) direct polycondensation of LA by the elimination of 
water as a byproduct and the inverse reaction, the PLA hydrolysis with the 
consumption of water; (b) ring opening polymerization ROP of lactide and the inverse 
reaction, the depolymerization of PLLA. Additionally, the route to produce the lactide 
by the LA hydrolysis. Reproduced with permission.96 Copyright 2006, Wiley-VCH.  
 
The preparation conditions, the molecular weight and the thermal history 
influence the crystalline preference of PLLA and its thermal transitions. In addition, 
PLLA can undergo crystal reorganization through polymorphic transitions during 
heating. For instance, without a controlled process the obtained PLLA is generally 
amorphous due to the slow crystallization rate. 87,94,97,98 
 
The most stable crystallographic form of PLLA is the orthorhombic α-
crystal, with parameters a = 10.683 Å, b = 6.170 Å, and c(chain axis) = 28.860 Å.99 
This crystal form is obtained upon crystallization at temperatures higher than about 
120 °C.93-95 Isotactic macromolecular chains adopt this crystallographic form by 
taking a 103 helical conformation (i.e. 10 units in 3 turns).
100,101 The orthorhombic unit 
cell have two chains and the a/b ratio indicates that the helices pack in a hexagonal 
manner even though the symmetry of the cell is orthorhombic.100 On the other hand, 
(a) (b) 
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the metastable α’-crystals (or δ-crystal) is produced by bulk crystallization at 
temperatures lower than 120 °C. This phase is considered as a disordered α-form 
crystal and can be transformed into the α-form.102,103 Other crystallographic form that 
PLLA can adopt is the ß-form crystals comprised by 31 configuration (i.e. 3 units per 
turn) with a trigonal unit cell.104 This crystallographic form is known as “frustrated ß-
Phase” because of the central helix cannot establish the same interactions with its 
neighbors as the other surrounding six helix do in this structure, and must adapt to an 
unlikely environment.87 Finally, the last crystallographic form for the PLLA is γ-form, it 
can be obtained by epitaxial crystallization.87 
 
1.3.1.2. PLLA hydrolytic degradation 
 
Polylactides undergo hydrolytic degradation, taking place at bulk or 
surface erosion by the random scission of the ester backbone, which is a chemical 
group easily hydrolysable. In the bulk erosion the water diffusion is faster than 
polymer degradation, the material degradation is homogeneous. Instead, in surface 
erosion, the degradation is faster than water diffusion, and the material is eroded 
from the external surface and the erosion moves towards the interior of polymeric 
matrix.71,87 This hydrolytic chain cleavage has shown to occur preferentially in the 
amorphous regions, resulting in an increase in polymer crystallinity.105 The polymeric 
degradation product is the LA, which is also the human metabolic byproduct and is 
converted into water and carbon dioxide, representing no toxicity issue.106 The 
hydrolytic degradation and therefore the degradation rate of PLA depends on a 
plenty of variables, including molecular weight, chemical composition, crystallinity 
degree, stereochemistry, morphology (e.g. porosity of the matrix), as well as the 
environmental conditions.71,87 Table.1 summarizes the effect of some main 
parameters on the PLA hydrolytic degradation 
 
The control of the mentioned variables and the prior knowledge of the 
hydrolytic degradation mechanism, including the biodegradation conditions are 
fundamental for the medical applications of PLLA.87 Thus, the stages of the PLA 
hydrolytic degradation can be summarized in: 1) diffusion of water into the material; 2) 
hydrolysis of chains in the amorphous region due to the lower resistance to water 
attack; 3) decrease of molecular weight as a result of hydrolytic cleavage of ester 
bonds and formation of water-soluble compounds; finally 4) hydrolysis of the lamellae 
of the crystalline phase, which can undergo autocatalytic degradation due to the 
acidic degradation products and  the increasing concentration of carboxylic acid at 
chain ends.87,107 
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Table 1. Effect of temperature, pH, Mw and crystallinity on the hydrolytic degradation 
of PLA  
 
Property Effect on the hydrolytic degradation of PLLA 
Temperature 
Mathematical deduction of kinetic degradation´s temperature 
dependence, assuming an Arrhenius-like dependence : 
 
     (    ) 
   (
 
  
 
    
)
 
 
where T is the temperature, KR is the rate constant of hydrolysis 
from experimental data, Tref is the reference temperature, ER is the 
Arrhenius constant, which is about 10,000 K. At T values lower 
than Tg (Tref) the KR becomes much slower.
87 
pH 
pH influence on the reaction mechanism and on the kinetics of 
degradation. The hydrolytic degradation can be acid-catalyzed, 
base-catalyzed, and uncatalyzed.108,109 pH dependence is also 
related to the different reactivity of the ester bonds: terminal esters 
degrade faster than backbone esters according to the preferential 
chain-end scission mechanism.87 However, the cleavage of 
backbone esters results in a faster Mw drop.110 
 
De Jong S., et al. 111 report the degradation kinetics constants 
collected at 37 °C at different pH values for LA oligomer with an 
average polymerization degree of 7. They increased the pH from 1 
to 10 and observed that initially the rate constant decreases 
reaching a minimum at pH of about 4, and then increases at higher 
pH values. 
Mw 
Mw influence was reported by Sara KS., et al.
116 They observed 
that lower Mw values accelerates the hydrolytic degradation, due to 
the higher molecular mobility, higher density of hydroxyl groups 
and hydrophilic terminal carboxyl groups, as well as higher 
probability of formation of water-soluble oligomers and monomers. 
Thus, the water diffusion and water content increase, catalyzing 
the PLLA degradation. 
Crystallinity 
The crystallinity influence lays in the preference of hydrolytic 
cleavage of chains in the amorphous regions rather than the 
crystalline regions of PLA as a result of the restriction imposed by 
the rigid crystalline regions on the water molecules to access the 
polymeric chains. Likewise, as the amorphous regions hydrolyzes, 
the ratio of crystalline regions increases.113 
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1.3.1.3. Commercial application  
 
Currently, the biopolymers can be classified into 3 groups: first, second 
and third generation related to bioabsorbable (degradable), biodegradable (eco-
friendly) and biobased (renewable resource) polymers, respectively. The historical 
application of PLA material allows its classification in each group.87 Though the PLLA 
brittle character, modifications made to PLA since its early application enabled the 
unlimited options to use PLA materials.114 As first generation, PLLA was used for 
fabrication of sutures, prostheses and scaffolds. As second generation, PLLA was 
developed to replace some plastics for short-life applications. Finally, as third 
generation polymers, PLLA was for long-term applications such as automobile 
parts.87  
 
As biobased polymer, the PLA and its copolymers are manufacture by 
pharmaceutical and food companies such as Durect and Purac (now Total Corbion) 
corporations to supply bioplastics, commercializing products such as Durect 
LACTEL® Absorbable Polymers and Luminy® PLA. Specifically, because of the 
PLLA mechanical, thermal and degradable properties, it has been considered an 
ideal biomaterial for applications, such as orthopedic fixation devices. Medical 
devices companies such as Depuy Synthes and Arthrex manufacture a variety of 
PLLA-based orthopedic products including materials for medical interventions of hip, 
knee and shoulder. 
 
1.3.2. Poly(ethylene oxide) 
 
The PLA hydrolytic degradation can be controlled or tailored by some 
strategies and approaches such as increasing the hydrophilicity of PLA.115-117 For 
instance, generating hydrophilic surfaces by copolymerization or crosslinking; 
modifying the morphology (e.g. generation of pores); and enabling the hydrolytic 
attack by blending with a hydrophilic polymer. 118-120 The development of polymeric 
blends containing PLLA and poly(ethylene oxide)(PEO) (PLLA/PEO) has been widely 
reported, to study the influence of hydrophilicity of PEO to modify the degradation of 
PLLA as well as the drug release.115-117 PEO is a hydrophilic polymer that possesses 
interesting chemical properties. Some chemical characteristics of PEO, studies of 
polymeric blends with PLLA will be cited latter herein. 
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1.3.2.1. PEO chemical properties 
 
The common name of the polymer of ethylene oxide is poly(ethylene oxide) 
or poly(ethylene glycol)(PEG) and according to IUPAC the name is poly(ethylene 
oxide).121 PEO is a crystalline, thermoplastic, hydrophilic and uncharged polyether, 
characterized for being a water-soluble polymer, with the linear formula H-[-
OCH2CH2O-]-H. The chemical structure shows the end hydroxyl for low Mw PEO 
(Fig.10).126,123 PEO is commercially available in a wide range of molecular weights 
from ethylene glycol, diethylene glycol to several million or more (Mn 120-
136,000).121-123 According to the Mw the adopted nomenclature is polyethylene 
glycols for lower Mw, which are relatively viscous fluids to wax-like solids, while higher 
Mw polymers are named as PEO and are thermoplastics. Both polymeric classes 
display different properties conferred by the Mw difference since the concentration of 
end-groups in the low Mw PEGs is higher than PEOs.
126 The thermal properties 
depend on Mw. For instance, in low Mw PEO (600 g/mol) the Tm is about 20 to 25 °C 
and for high Mw PEO (50,000 – 160,000 g/mol) the Tm is about 67 °C. Moreover, the 
Tg has been reported as well, ranging from -50 to -70°C.
121,126,124 
 
The PEO synthesis was initially explored by Lourenco and Wurtz,125,126 at 
almost in the same time. The early synthesis used ethylene oxide, which is a three-
membered ring containing an oxygen atom, highly reactive due to large strain energy 
(Fig.10).125 The polymerization of ethylene oxide may be classified into anionic using 
an alkali, cationic using a Lewis acid, and coordinate anionic polymerization.126 The 
first high Mw PEO synthesis was reported in 1958 using alkaline earth carbonates.
127 
Currently, anionic polymerization using ethylene glycols yield low polydispersity 
polymers.121,126 
 
PEO can crystallize from the melt. Initially, crystal nucleation occurs and 
afterwards the growth of the nuclei takes place. In the crystalline state, the 
crystallographic form adopted by PEO is a 72 helical conformation (i.e.7 units in 2 
turns).The crystallographic unit cell contains four molecular chains and is monoclinic 
with parameters a = 8.16 Å, b = 12.99 Å c (chain axis) = 19.30 Å, and β=126°5’.126,123 
 
Fig. 10. Structural formula of PEO (left) and structural formula of ethylene oxide 
(right). 
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PEO undergoes oxidative attack resulting in the degradation of the 
polymer, which is accelerated by heavy metal ions, oxidizing agents, strong acids, 
and ultraviolet light.122 Besides, this polyether can be enzymatically biodegraded, by 
PEO-dehydrogenase, PEO-aldehyde-dehydrogenase and PEO-carboxylate-
dehydrogenase yielding terminal carbonyl groups followed by the release of C2 units 
as glyoxylic acid.121 Also, the polymer degrades by autoxidation forming 
hydroperoxide species, which decompose and cause polymer chain cleavage.122 
 
One of the most interesting properties of PEO is its solubility in water in 
spite of being soluble in organic solvents such as chloroform. However, PEO is 
insoluble in aliphatic hydrocarbons and at low room temperature is soluble in 
aromatic hydrocarbons. In water, PEO has an inverse solubility-temperature 
relationship, in which, increasing the temperature of aqueous solution (near to the 
boiling point of water), leads to the polymer precipitation. PEO also exhibits an upper 
consolute temperature or an upper critical solution temperature, which depends on 
polymer concentration and molecular weight.122,127 For instance, for polymeric 
concentrations lower than 0.2% the observed precipitation is known as a cloud 
point.122 
 
According to Kjellander and Florin,128 the solubility of PEO in water is 
conferred by the suitable structural fit between them. They suggested that PEO can 
be fitted into the tetrahedral water lattice with minimal perturbation of the water 
structure, where the lattice points are occupied, either by water or by ether oxygen.. 
Additionally, the inverse solubility-temperature relationship aforementioned can be 
interpreted as disordering of ‘hydration shells’, which are conformed by highly 
oriented water molecules that surround the polymer molecule. This hydration shell 
water is characterized by unfavorable entropy that is overcome by the low enthalpy 
due to the water and PEO interaction. With increasing temperatures, the hydration 
shell is disrupted due to thermal motion and entropy contribution overcomes the 
enthalpy contribution, allowing a better polymer-polymer interaction causing the 
system phase-separation. 122,123,130 
 
The hydrophilic character of PEO confers a biological advantage in its 
application as a biomaterial. It seems that the suitable properties of PEO such as the 
minimal interfacial free energy with water and good structural fit; high mobility and 
large excluded volume are related to the decreased protein adhesion, making it 
protein-resistant. The protein adhesion represents a problem that may lead to further 
thrombus formation in the material surface. The effectiveness in the protein-
resistance of PEO suggests that it could improve the blood-compatibility of 
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biomaterials. Thus, immobilizing hydrophilic polymers in surfaces, such as PEO could 
enhance some biomaterial properties.123 Some strategies are used to accomplish the 
PEO mobilization surface. For example, the non-covalently attachment in the surface, 
using of a common solvent that allows the surface of biomaterial to swell and the 
water soluble polymer molecules entrance into the loosed polymeric network, 
followed by, the fast collapse of the swollen interface provoked by water, entrapping 
the hydrophilic polymer within the biopolymer network.129 
 
Among the different applications of PEO in materials, the blending with 
PLLA has been explored to improve some mechanical and thermal properties. These 
properties are influenced by the polymeric interactions, which are nothing but the 
miscibility of the system that explains the phase behavior and the morphology of the 
blend. The understanding of the polymeric interactions can be archived by 
thermodynamic studies, such as Differential Scanning Calorimetry (DSC).130 
Currently, the miscibility of PLLA/PEO blends with different Mw and concentrations 
obtained by solvent casting technique or melt-blending are widely studied according 
to their thermal properties by DSC,.131 Younes et al.132 studied the miscibility of 
PLLA/PEO blends comprising high Mw PLLA with high and low Mw PEO. Analyzing 
the Tm depression, they concluded that the Tm of PEO is more susceptible to the 
PLLA presence and when one of the components is present at more than 20 wt%, it 
is able to crystallize.  
 
Other miscibility studies by DSC showed that blends containing up to 50 
wt% of high Mw PLLA with high Mw PEO displayed both single Tg and Tm decreased 
on blending, suggesting miscibility in the amorphous phase.133 Besides, the hydrolytic 
degradation rate of blends was also increased compare to pure PLLA. On the other 
hand, for high Mw PLLA and low Mw PEO blended films, the Tm of PLLA linearly 
decreased with the increase in the PEO content. In addition with 20 wt% PEO, the 
alkali hydrolysis rate was accelerated due to the porous structure of the blend. 134 
Same trend was observed in other study.135 Studies of enzymatic hydrolysis were 
reported as well. The degradation of the blends containing high Mw PLLA and low Mw 
PEO was accelerated and it was shown that blends with up to 30 wt% and 20 wt% 
PEG are miscible for amorphous and semicrystalline PLAs. 136,137 
 
Finally, applications of PLLA/PEO blend comprehend a variety of options 
as biomaterials, especially for drug delivery purpose. Such studies includes 
development of nanoparticles,138 hydrogel structures,139 nanofibers140 and 3D-printed 
scaffolds,141 highlighting the helpful influence of PEO in both processing and 
degradation of PLLA in biomaterials. 
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The purpose of this project was the development of polymeric coatings of 
PLLA doped with SNAP by spin coating, capable of releasing NO in a sustainable 
fashion with the aim to enhancing the biocompatibility of medical devices, which 
could contribute to the studies related to NO release by materials. In addition, as the 
kinetics of NO release in the exogenous administration by hydrophobic polymeric 
coatings using PLLA may be governed by the low rate of PLLA degradation, due to 
its hydrophobicity of PLLA, coatings of PLLA/PEO may to increase the permeation of 
water into the polymer bulk and accelerate NO release from SNAP, thereby offering a 
new way of controlling the release of NO from the material. 
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2. AIMS 
 
2.1. General aim 
 
The main aim of this project was the characterization of NO-releasing 
coatings prepared by spin coating, comprised of poly(L-lactic acid) (PLLA) containing  
S-nitroso-N-acetyl-D-penicillamine (SNAP) as a NO-donor, capable of delivering NO 
locally during prolonged periods.  
 
2.2. Specific aims 
 
 To characterize the kinetics of hydrolytic degradation of materials and its 
impact on the modulation of NO release profiles. 
 
 To characterize the effect of multi coatings on the kinetic profile of NO 
released from the materials. 
 
 To characterize the effect of blending PLLA with poly(ethylene oxide) (PEO) 
on the NO-releasing and hydrolytic properties of the materials. 
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3. EXPERIMENTAL SECTION 
3.1. Materials 
 
L-lactic acid 84.5-85.5 %, stannous(II) chloride dehydrate 98 %, m-xylene 
99 %, p-toluenesulfonic acid monohydrate 98 %, N-acetyl-D-penicillamine (NAP) 
99 %, hydrochloric acid (HCl) 37 %, sodium nitrite (NaNO2) 99 %, vanadium (III) 
chloride (VCl3) 97 %, potassium chloride 99 %, PEO Mv 400,000 g mol
-1 (Sigma-
Aldrich Chem. Co, USA), sodium iodide (NaI) 95 %, sodium nitrate (NaNO3) 99 % 
(Fischer Scientifgic, USA), tetrahydrofuran (THF), chloroform (CHCl3), acetone, 
EDTA disodium salt dehydrate 99 %, methanol 99.8 %, sodium chloride 99 %, 
sodium phosphate dibasic anhydrous 99 %, potassium phosphate monobasic 
anhydrous 99 % (Labsynth, Brazil) and sulfuric acid 98 % (Tedia Company, Inc., USA) 
were used as received. Ultrapure water (resistivity 18.2 MΩ cm at 25 °C) obtained 
from a Milli-Q® Direct-Q® 3 UV purification system (MerckMillipore, USA) was used 
in all procedures. Commercial polypropylene (PP) sheets were used without further 
treatment. 
 
3.2. Methods 
3.2.1. Poly(L-lactic acid) (PLLA) synthesis 
 
PLLA was synthesized by a research group member, based on the 
procedure described in previous work.65 Briefly, lactic acid solution (85 wt%) was 
heated in a reaction flask under reflux and magnetic stirring in the presence of 
stannous (II) chloride dihydrate as a catalyst, p-toluenesulfonic acid monohydrate as 
co-catalyst and m-xylene as a solvent. A Dean-Stark trap was used to collect the 
water/m-xylene azeotropic mixture distilled from the reaction. The reaction was 
allowed to proceed for 24 h. PLLA was further purified by recrystallization/dissolution 
in methanol/chloroform. Afterwards, dried in vacuum oven (Büchi, Glass Oven B-585) 
at 60 ºC and 15 mbar for 24h and post-dried by lyophilization for 24 h. 
 
3.2.2. S-nitroso-N-acetyl-D-penicillamine (SNAP) synthesis 
 
SNAP was synthesized by a research group member, based on the 
procedure described in previous work.65 Briefly, the S-nitrosation of NAP was carry 
out with a molar ratio 1:2 (NAP:NaNO2) in an acidified methanol solution with molar 
ratio 1:2 (HCL:H2SO4) for 30 min. Subsequently, the solution was stirred in an ice 
bath for SNAP precipitation. Crystals were collected by vacuum filtration, washed 
with cold water and dried by lyophilization for 24 h.  
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3.2.3. Coating model surfaces by spin coating 
 
PP sheets (ca. 4 cm2) (Fig.11) used as model surface were cleaned 
ultrasonically twice using ethanol, isopropyl alcohol and deionized water during 5 min 
and dried at room temperature. The choice of PP as a model surface was based on 
its previous applications in clinical interventions as implantable material.142 In order to 
obtain a homogeneous thin film a spin-coater (Laurell Technologies Corporation, WS-
650MZ-23NPP) was used to coat the PP surface. Different concentrations of 
polymeric solutions were used, 5, 10, 20 and 40 g L-1 of PLLA. The spin coater 
program used comprehended basically 3 programming steps; 1) solution deposition, 
2) spin up and 3) spin-off. Two variables in each step, target speed and the 
corresponding time were fixed. Table 2 shows the different spin coating used for 
each step in the coating process.  
 
 
Fig. 11. Cleaned polypropylene sheets used as a model surface for spin coating. 
 
In the first step, solution deposition, at which the polymeric solutions is 
poured on the substrate, two speeds were tested, 100 and 300 rpm. The 300 rpm 
rotating speed allowed a uniform deposition of the polymeric solution; there was a 
good pre-spread of the solution without drop formation. The 100 rpm seemed to be 
too slow and led to the formation of a drop, resulting in a heterogeneous coating.  
 
In the second step, spin-up, 4 speeds were tested: 500, 1,000, 1,500 and 
2,000 rpm. The lowest speed led to heterogeneous coatings with spots and solids in 
the 4 concentrations. Similar results were obtained with 1,000 rpm except for the 40 g 
L-1 concentration. The 500 and 1,000 rpm speeds showed to insufficient to spread 
the polymer solution uniformly before solvent evaporates. The 1,500 rpm speed gave 
better results than 500 and 1000 rpm speeds in terms of uniform spreading; although 
opaque films were obtained. Finally, the best speed was 2,000 rpm, which led to 
homogeneously spread films all the concentration used. 
 
 
40 
 
Table 2. Spin coater conditions used to coat model PP surfaces with PLLA solution. 
Step Time/s Rotating speed/rpm 
1 3 
100 
300 
2 60 
500 
1,000 
1,500 
2,000 
3 30 500 
 
In the third step, the speed was decreases until 500 rpm during 30 s for 
allowing solvent evaporation in the coating already formed. It is important to note that 
in addition to finding the optimal programming steps, the final result obtained in the 
coatings depends also on standardizing the manual addition of the polymeric solution 
whose 100 µL must be added at the same rate during 3 s. The above mentioned 
steps are represented in the speed profiles shown in Fig.12a, for the addition of 100 
µL of polymeric solution in THF.  
 
 
 
  
  
Fig. 12(a) Spin coating speed profile used for coating of PP substrates with PLLA-
SNAP solutions in THF, (b) schematic procedure related to each step: (I) solution 
deposition, (II) spin up, (III) spin off and coated film. 
*The green color is just for schematic illustration purpose. 
 
 
(a) 
(b).II (b).III 
(b) (b).I* 
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In the case of blend-coated films of PLLA/PEO, 60 g L-1 of polymeric 
solution was prepared with mass ratio 70:30 (PLLA:PEO). The blended solutions 
were doped with SNAP 10 wt% relative to the mass of the solid polymer, by 
previously dissolving SNAP in an appropriate amount of THF. Afterwards, the SNAP-
doped solution was deposited on PP substrates by spin coating as described above 
(Fig.12b). 
 
Fig.12b schematically shows the main steps in the coating process: 
solution deposition (I), spin-up (II) and spin-off (III) respectively. In some cases, a 
second deposition on the same surface was realized. No drying time was used 
between depositions. Afterwards, the coated model surfaces were dried in a vacuum 
oven (40 °C, 30 mbar) during 3 h, protected from light, and then stored at room 
temperature also protected from light. 
 
3.2.4. PLLA/PEO blend film preparation 
 
In order to study the polymeric interactions, the miscibility of the 
PLLA/PEO blend was characterized based on the thermal characterization by 
Differential Scanning Calorimetry (DSC). PLLA/PEO 70:30 (wt/wt) blends were 
previously obtained by solvent casting (Fig.13). The PLLA/PEO solution (60 g L-1) in 
CHCl3 was prepared using a vortex spinning machine (Daigger, Vortex Genie® 2). 
2.5 mL of blended polymeric solution was poured on a Teflon® plate (diameter 3 cm) 
and solvent evaporation was conducted at room temperature for ca. 24 h. Afterwards, 
to complete solvent removal the sample was dried in a vacuum oven (40 °C, 30 mbar) 
for 3 h.  
 
Fig. 13. Schematic ilutration of the procedure used to obtain blended  PLLA/PEO 
films by solvent casting. 
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3.2.5. Physical chemical characterizations  
 
3.2.5.1. Attenuated Total Reflectance-Fourier Transform Infrared 
Spectroscopy (ATR-FTIR) 
 
Infrared spectra were obtained in Attenuated Total Reflectance (ATR) 
mode in a FTIR Cary 630 spectrometer (Agilent, Santa Clara CA) fitted with a 
diamond crystal type II ATR accessory (penetration 2 mm, active sampling diameter 
200 mm) in the range of 4000 – 400 cm-1. The coatings were pressed directly against 
the crystal for analyses. 
 
3.2.5.2. X-Ray Diffraction (XRD) 
 
An X-ray diffractometer (Shimadzu, XRD7000), operating at 40 kV with Cu 
Ka radiation (λ=0.154 nm), was used to obtain diffractograms in the 5 – 50º 2θ range. 
Pure solid PLLA and SNAP were analyzed as well as the PLLA-SNAP coatings. 
 
3.2.5.3. Gel Permeation Chromatography (GPC) 
 
PLLA molecular weight distribution was determined by GPC using a 
Viscotek chromatograph (Model GPCmax VE 2001), equipped with a refractometric 
detector (Viscotek Model VE 3580) and three columns Shodex KF-806M (300 mm x 
8 mm, 10 µm) connected in series using polystyrene standards. Experiments were 
performed at 40 ºC. Filtered and degassed THF (HPLC grade) was used to prepare 
the PLLA solution in a 7.5 mg mL-1 concentration. 100 µL of polymeric solution 
(filtered with a PTFE membrane with a pore size of 0.45 µm) was injected with a 1 
mL min-1 eluent flow rate. The calibration curve was plotted by OmniSEC (Vicotek) 
software from the peak molecular weight (Mp) of polystyrene standards (Viscotek) 
(1,080-1,900,000 g mol-1). 
 
3.2.5.4. Thermal properties 
 
Differential Scanning Calorimetry (DSC) was carried out to determine the 
glass transition temperature of pure solid PLLA in the range of -10 °C to 220 °C at a 
10 °C min-1 heating rate; as well as pure solid PEO and PLLA/PEO blend obtained in 
the range of -90 °C to 220 °C at a 20 °C min-1 heating rate. DSC curves were 
normalized with respect to sample mass (ca 5 - 10 mg). The thermograms were 
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obtained in a calorimeter TA Q-100 (New Castle, DE) and recorded using the 
software of TA Instruments Universal Analysis 2000. 
 
3.2.5.5. Contact angle measurements 
 
Contact angles between the air/water interfaces were measured with an 
optical tensiometer (Theta Attension, KSV Intruments), at 17 °C, using Milli-Q water 
drops. The images of the water drops on the coated substrate were recorded with a 
digital camera and were analyzed using the software provided by the manufacturer. 
Right and left angles obtained were used to calculate the average angles, expressed 
herein as mean ± SD.  
  
3.2.5.6. Scanning electron microscopy / Energy Dispersive Spectroscopy 
 
The morphology of the samples was investigated in a Quanta FEG 250 
(FEI) scanning electron microscope (SEM) equipped with an energy dispersive X-ray 
spectrometer (EDS, Oxford). Films were mounted on aluminum stubs with a double-
side carbon tape, sputter coated in a high-vacuum gold-palladium (80/20) sputter-
coating unit (Balt-Tec, MCS 010) for SEM investigation, while samples used for EDS 
were coated with evaporated carbon. 
 
3.2.5.7. NO release measurements  
 
NO released was measured by chemiluminescence, using a NO analyzer 
(NOATM, Sievers 280i), operated with an O2 pressure of 6.0 psig and N2 pressure 0.4 
psig above the equilibrium pressure (ca. 7.2 Torr). The NO detection is based on a 
gas-phase chemiluminescent reaction between ozone (generated by an electrostatic 
ozone generator and high voltage transformer, ca. 2 v/v% from oxygen) and the NO 
released, according to Eq.12. Afterwards, the excited    
  specie releases energy 
(Eq.13), which is quantified by the NOA´s detector. 
 
         
                                                                   (12) 
   
                                                      (13) 
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 The NOA was calibrated according to the manual for measurements of 
NO and nitrate/nitrite (Fig.S-1). All NO release measurements were conducted in 
triplicate. Data reported herein are all expressed as mean ± SD. Comparison of 
means using student's t-test was used to analyze the statistical differences between 
different sets of samples. For these calculations GraphPad QuickCalcs statistical 
calculator was used. Values were considered statistically significant for all tests 
considering the p < 0.001 (one asterisk) and p < 0.02 (two asterisks). 
 
3.2.5.7.1. NO release profile and kinetics 
 
The real time NO release under physiological conditions was obtained by 
chemiluminescence. Briefly, samples (ca. 2 - 3 cm2) were placed into an inert sample 
holder (polyethylene mesh) kept pending by a stainless steel wire and submerged 
into a phosphate-buffered saline solution (PBS) (100 µM EDTA, pH 7.44) contained 
in the sample vessel at 37 °C in dark (Fig.14a). The NO released was carried to the 
chemiluminescence detection chamber by N2. Finally, the NO released per squared 
area was calculated assuming a flat surface on a single side of the sample.  
 
 
Fig. 14 Schematic illustration for NO detection using a Nitric Oxide Analyzer (a) setup 
for short-term kinetic NO release and quantification measurements. The sample was 
placed into an inert sample holder pending from a stainless steel wire. (b) setup for 
quantification of long -term NO release. 
Injection port 
with septa 
Inert gas 
supply (N2) 
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Reducing agent 
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IFD O2 
Drain 
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Drain 
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Gas bubble 
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45 
 
3.2.5.7.2. Quantification of short-term NO release 
 
The quantification of SNAP superficial of the coatings under accelerated 
conditions was obtained by chemiluminescence. The SNAP quantification is 
reflected by a short-term NO release, obtained by SNAP reduction by an alkaline 
ascorbate medium (160 mM, pH 11), in which the SNAP´s SNO groups are 
selectively reduced to free NO and its parent thiolates.143 These experiments were 
also performed in the NOA using the setup shown in Fig.14a and similar precautions 
described above. Impregnated SNAP was decomposed simultaneously through both 
ascorbate reduction pathway and the photoinitiated decomposition pathway using a 
LED fiber optic illuminator (LMI-6000, Fiber-Lite®) with a visible light source.  
 
3.2.5.7.3. Quantification of long-term NO release, in vitro hydrolysis 
 
The NO release under physiological conditions for prolonged periods was 
obtained by chemiluminescence. This indirect NO quantification was based on the 
reduction of nitrite and nitrate species, using the vanadium (III) chloride method, 
according to the NOA manufacturer’s specifications. VCl3 in hydrochloric acid was 
used to reduce nitrite and nitrate species to NO, in order to quantify the cumulative 
NO release (Eq.14). Nitrite and nitrate species were produced by the NO oxidation 
during the incubation period (Eq.4). The samples were immersed in PBS at 37 ºC 
protected from light. Aliquots of 50 µL were taken for the determination of long-term 
NO release. After aliquot extraction the samples were placed in fresh PBS. The 
analysis was performed at 85 °C, containing a saturated VCl3 solution in HCl. The 
gas flow was previously washed in a washing flask containing NaOH solution to 
prevent HCl to reach the detector (Fig.14b). The calibration curve was performed 
using nitrate standard solutions. (Fig.S-2). 
 
          
               
                     (14) 
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4. RESULTS AND DISCUSSION 
 
4.1. PLLA-SNAP coatings preparation and characterization  
 
PLLA was obtained as a white fine powder, soluble in THF and chloroform, 
with weight average molecular weight (Mw) of 3,582 g mol
-1. Molecular weight and 
distribution obtained by GPC is shown in Fig.15. The chromatogram indicates the 
presence of two distinct populations, in which the higher Mw is in a lower 
concentration (represented by a shoulder in approximately 31 mL). As a result, the 
low molecular weight PLLA, so-called a PLLA oligomer, showed dispersity (Ð) equal 
to 1.292. This is characteristic of a step-growth polymerization reaction. The number 
average polymerization degree DPn (Eq.15) given by the quotient between the Mn 
(2,771 g mol-1) and the repeat unit (lactic acid) average molecular weight (M0 = 72.06 
g mol-1), corresponds to an average value of 38 repeat units per polymeric chain. 
    
 ̅ 
 ̅ 
                                                         (15) 
  
Fig. 15. GPC chromatogram of PLLA (a) and its corresponding molecular weight 
distribution (b). Number average molecular weight (Mn) and weight average 
molecular weight (Mw) are indicated by the red dashed lines. 
 
The pure solid PLLA thermogram is shown in Fig.16. Three thermal events 
can be observed; the glass transition temperature (Tg), the crystallization temperature 
(Tc) and the melting temperature (Tm). The Tg at 39.5 ºC can be observed in the 
magnification of the inset corresponding to the temperature at which the polymer 
undergoes phase transition from a glassy state into a rubbery. 
(a) (b) 
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Fig. 16. Thermogram of PLLA by DSC (second heating after erasing the thermal 
history) showing the thermal events. From the left to the right; the glass transition 
temperature, the crystallization temperature and the melting temperature (bimodal 
event). Additionally, the crystallization and melting enthalpies values are shown. The 
inset figure shows a magnification of the Tg region.  
 
The Tg value allows estimating Mn can be through the empirical Flory-Fox 
equation (Eq. 16).144 
 
     
  
 
  
                                                      (16) 
 
where   
  is the limiting value of the glass transition temperature at very high Mn and 
k is a constant of a given polymer, which represents the excess free volume, 
associated with the dependence of the Tg with the molecular weight.  
 
This approximation implies considering that the lower the molecular weight the 
higher the chain ends contribution to the overall polymer free volume.145 In this case, 
the Mn calculated was 2,477.5 g mol
-1 for Tg = 39.5 ºC,   
  = 58 ºC and k = 5.50 x 104, 
values extracted from the literature for PLLA.146 The empirical Mn obtained was found 
to have about the same order of magnitude as the Mn obtained by GPC. 
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After Tg event, an exothermic Tc is observed at 95.6 ºC, due to PLLA cold 
crystallization and finally, two endothermic peaks at 111.3 and 123.9 ºC, Tm, due to 
the melting of the crystalline phase are observed. The occurrence of two distinct 
endothermic peaks (bimodal event) is caused by the recrystallization and change in 
PLLA crystal structure during heating:147 The α´ crystal is obtained at Tc below 120 ºC 
as a disordered crystal with hexagonal packing, that upon heating, gain mobility and 
is transformed into and ordered α form.148 These endothermic peaks are not 
observed in the thermal history (Fig.S-3), which only depicts multiple melting peaks 
during heating, due to the PLLA polymorphism, whereas during cooling no 
crystallization peaks are observed, since the crystallization kinetics from the melt is 
slow and cannot be detected. Furthermore, the enthalpies of crystallization (ΔHc) and 
melting (ΔHm) calculated by the quotient between the peak area and the heat rate, 
are very similar (19.9 J g-1 and 20.3 J g-1, respectively), as expected. 
 
Solid pure SNAP was characterized by ATR-IR as shown in Fig.17a. The 
main peaks related to the ν(N-H) and ν(N=O) stretching vibrations are shown by the 
black arrows. A sharp peak at 3337 cm-1 is assigned to the N-H bond stretching 
vibration of secondary amines (Fig.17b).149 A second weaker band at 1930 cm-1 and 
the intense peak around 1493 cm-1 can be assigned to stretching vibrations of the 
N=O.39 These results confirm SNAP synthesis. 
 
Fig. 17(a) Vibrational spectra of powdered SNAP. Main peaks, ν(N-H) and ν(N=O) 
stretching shown by the black arrows. (b) SNAP chemical structure highlighting the 
amine group and NO groups responsible for the peaks highlighted in (a). 
 
Fig.18 shows a schematic illustration of the coating conformation and the 
different PLLA-SNAP coated films obtained. Fig.18a shows a schematic illustration of 
(a) (b) 
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a monolayer sample where the orange coils represent the PLLA matrix, the green 
solids represent the SNAP molecules dissolved in the polymeric matrix and the 
smooth base represents the PP substrate. Fig.18b and c depicts the schematic 
illustration of a bilayer samples, PLLA-doped second deposition and pure PLLA 
second deposition, respectively. 
 
 
 
 
 
 
 
 
             
 
 
 
 
Fig. 18. Schematic illustration of PLLA-SNAP coated films (a) PLLA-SNAP showing 
the composition of the coating. Green circle represent SNAP molecules and orange 
coils represents PLLA chains (b) Scheme of PLLA-SNAP/ PLLA-SNAP. (c) Scheme 
of PLLA/ PLLA-SNAP. 
 
Table.3 describes the different coatings obtained; along with the names of 
the coating, the SNAP concentration and the number of coatings onto the same PP 
substrate. 
 
The ATR-IR spectra of PLLA coat and SNAP-doped PLLA coatings are 
shown in Fig.19. The main characteristic peaks of PLLA, ν(C=O), ν(CH3) and ν(C-O-
C) stretching confirm the complete coating of the PP substrate as shown Fig.19a, 
blue spectrum. Table.4 shows the corresponding band assignments. Fig.19a shows 
the spectrum SNAP (in green), including the weak band at 3347 cm-1, assigned to the 
N-H bond stretching. Fig.19b shows a magnification of the spectrum in (a), showing 
the band at 1505 cm-1, assigned to the N=O bond stretching vibration. These results 
confirm that SNAP is effectively embedded into the PLLA matrix. 
(a) (b) 
(c) 
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Table 3. Samples obtained by spin coating showing the concentration of SNAP 
relative to the solid polymer (50 g L-1) or to the solid polymeric blend 70:30 (60 g L-1) 
and the number of layers. 
Name SNAP wt% Coating 
PLLA-SNAP 10 10 Monolayer 
PLLA-SNAP 20 20 Monolayer 
PLLA-SNAP/PLLA-SNAP 10 10 Bilayer 
PLLA-SNAP/PLLA-SNAP 20 20 Bilayer 
PLLA coat 0 Monolayer 
PLLA/PLLA-SNAP 10 10 Bilayer 
PLLA/PLLA-SNAP 20 20 Bilayer 
PLLA/PEO-SNAP 10 10 Monolayer 
 
 
 
 
Fig. 19. Vibrational spectra of PLLA coat and PLLA-SNAP 20 (a) dashed rectangles 
show the main PLLA peaks and the green arrows indicate main SNAP peaks.(b) 
Scaling up the spectra region showing the stretching vibration of N=O in 1505 cm-1.  
 
In order to further characterize the coating crystallinity, X-ray diffractometry 
was performed. Fig.20a shows the X-ray diffractograms of pure solid PLLA, solid 
SNAP and the bare PP substrate. The PP diffractogram shows characteristic peaks 
at 2θ of 14.2; 17.1; 18.8; 21.3 and 22.0º, which correspond to α crystalline form of 
PP.150 The XRD patterns of powdered PLLA at 2θ of 12.5; 14.8; 16.8; 19.1 and 22.4º 
exhibited the typical characteristic peaks of PLLA which correspond to the β-form, an 
orthorhombic unit cell or the α-form, a pseudo-orthorhombic unit cell. The last is the 
(a) (b) 
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most stable crystal phases among the different types of PLLA crystal 
modifications.151,152 The diffractogram of the powdered SNAP, corresponds to the 
orthorhombic SNAP crystal structure already reported by Yaqi Wo., et al.68 The 
diffractograms in Fig.20b, shows the diffractograms of monolayer of PLLA-SNAP 10 
and PLLA onto PP, were only peaks of PP can be seen. The absence of PLLA and 
SNAP peaks in these samples can be attributed to the reduced thickness of the 
coatings, whose X-ray signals are insufficient to overcome the strong PP signals. 
 
Table 4. Wavenumber and assignments for the main characteristic vibrational bands 
of PLLA.153 
Absorption band position (wavenumber/ cm-1) Vibrational mode* 
2995 νas  (CH3) 
2945 νs CH3)  
1750 ν (C=O) 
1457  δab (CH3 )  
1386 δs (CH) 
1186,1083 and 1045 ν (C-O-C) 
869 ν (O-CH(CH3)-) 
*ν: stretching, νas: antisymmetric stretching, νs: symmetric stretching, δab: antisymmetric 
bending, δs: antisymmetric bending. 
 
SEM images allowed evaluating the surface morphology of PLLA and 
PLLA-SNAP coated films (Fig.21). It can be seen in Fig.21a and b that all PLLA 
coating surface displays cavities with polydisperse diameters in the range of 1 to 2 
µm. The high rate of solvent evaporation in the spin coating process is probably the 
origin of these cavities. The interaction time between the solvent and the polymer will 
define the morphology according to Neumann et al:154 If the interactions are weak the 
rate of solvent evaporation is high resulting in a heterogeneous surface, whereas 
strong interaction between the polymer and solvent will decrease the rate of solvent 
evaporation, allowing the formation of a more homogeneous surface.  
 
In comparison, the PLLA-SNAP 10 micrographs (Fig.21c and d) show a 
different morphology: no cavities can be observed on the surface and the coating is 
homogeneously distributed due to the colligative effect exerted by the SNAP in the 
polymeric matrix. SEM micrographs of the PP substrate showed a smooth surface 
with the absence any relevant morphological feature (Fig.S-4). 
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Fig. 20. X-ray diffractograms of pure samples PLLA, SNAP and PP substrate (a) and 
monolayers of PLLA and PLLA-SNAP coating (b). 
  
  
  
 
Fig. 21. SEM micrographs of monolayer coatings of PLLA coat (a) with magnification 
of the yellow square of (a) (b). PLLA-SNAP 10 (c) with magnification of the yellow 
square of (c) (d). 
(a) (b) 
(a) (b) 
(c) (d) 
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In order to obtain a cross section image of PLLA coat sample, the Cryo-
Ultramicrotome (Reichert ultracut, FC6) was used to slice the coated PP substrate. A 
representative cross section micrograph is shown in Fig.22. The thickness of single 
monolayer was found to be ca. 10 µm approximately.  
 
 
 
Fig. 22. SEM cross section micrograph of a monolayer of PLLA coating. Yellow 
arrows indicate the coating thickness. 
 
Micrographs of bilayer of PLLA-SNAP 10 also showed absence of cavities 
(Fig.23) and are similar to the morphology of the monolayer shown in Fig.21c and d. 
The small section of the second layer that can be seen in the bottom left of Fig.23, 
shows that there is an interface between the two coatings. This feature shows that 
during the deposition of the second coating there is not time enough for the solvent 
present in the second coating to dissolve the PLLA of the first coating, before is 
evaporates. 
 
The micrograph shown in Fig.24 displays a second deposition of pure 
PLLA layer above the first PLLA-SNAP layer. Pores (or cavities) appear in smaller 
amount and lager size. This morphology could be the result of the decreased solvent 
evaporation rate, due to a possible interaction with the first layer. The inner parts of 
the cavities resemble the morphology of PLLA-SNAP monolayer sample  
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Fig. 23 SEM micrographs of a bilayer coating of PLLA-SNAP 10 (a) and with 
magnification of the yellow square (b). The yellow arrow shows the first layer.  
 
  
 
Fig. 24. SEM micrographs of bilayer coatings of PLLA/PLLA-SNAP 10 (a) with 
magnification of the yellow square (d). The yellow arrows show two pores in the 
second PLLA layer. 
 
 
 
 
 
 
 
 
 
(a) (b) 
(b) (a) 
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4.2. Blend coatings preparations and characterization  
 
The viscous PLLA/PEO solution was poured on a Teflon® plate to obtain 
the blend by solvent casting as aforementioned. A white translucent film was 
obtained and used for the thermal characterization. Fig.25 and Fig.26 show the 
thermograms of pure solid PEO and of a PLLA/PEO 70:30 blend, respectively. 
Table.5 summarizes the thermal event values for pure PLLA, PEO and for the 
PLLA/PEO 70:30 blend. The PEO Tg could not be observed in the first heating (Fig.S-
5a). Possibly, this is due to its high crystallinity degree, which decreases the 
amorphous phase volumetric fraction, impairing Tg visualization. A large sharp 
endothermic peak, which is related to the melting process, with Tm is seen at 74.6 °C. 
In the cooling run, PEO crystallization is revealed by an intense exothermic peak, 
which is observed at 39.2 °C (Fig.S-5b). In the second heating (Fig.25), the Tg is 
located at -50.1 °C, in agreement with the literature.115,116 In the second heating, the 
melting enthalpy is smaller than in the first heating, due to the distinct thermal history 
and lack of an annealing time, which leads to incomplete crystallization. 
 
Fig. 25. Thermogram obtained by DSC (second heating after erasing the thermal 
history of the sample) of PEO. The inset shows the magnification of the Tg region. 
From the left to the right; the glass transition temperature and the melting 
temperature with the melting enthalpy value are indicated. 
 
The PLLA/PEO miscibility is related to the formation of a homogeneous 
system at a molecular level. It is found that most blends are immiscible due to the 
poor entropy contribution in polymer mixtures associated with the enthalpy of mixing 
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being positive or near to zero.115 Consequently, the free energy of mixing becomes 
positive, originating two crystalline phases. In contrast, in semi-miscible blends, 
intermediate dispersion or phase separation with a diffuse interface, due to the 
interpenetration of the different polymeric chains, may be observed. Miscibility can be 
evaluated by the Tg method, in which the blend is classified as miscible if it shows a 
single Tg and immiscible if the presence of distinct glass transitions is verified.
115 
Fig.S-6 and Fig.26 show the first and second heating of PLLA/PEO blend, 
respectively. The Tg of the blend cannot be seen due to its overlap with PEO melting 
peak as well as the PLLA Tg. On the other hand, Fig.26 displays what seems to be 
the Tg for both polymers, -29.8 ºC for PEO and -20.5 ºC for PLLA. For this reason, 
the Tg cannot be used as a guide to determine the PLLA-SNAP miscibility in the 
present case. 
 
 
Fig. 26 Thermogram obtained by DSC (second heating after erasing the thermal 
history of the sample) of the PLLA/PEO 70:30 blend. The inset shows the 
magnification of the Tg region. From the left to the right; the glass transition 
temperature and the melting temperatures with the melting enthalpies values are 
indicated 
 
The melting temperature depression is another method that has been 
used for characterizing blends containing crystalline polymers. Depending on the 
composition the melting peaks are expected to display a shift indicating a miscible 
blend, whereas a constant Tm indicates an immiscible system. Each of the 
crystallizable polymer of the mixture should display the Tm of the corresponding pure 
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polymer.115,155 It can be seen in Fig.26 that in the PLLA/PEO 70:30 blend the 
endothermic peak underwent a great reduction in the crystallization (table 5). In 
addition, the melting peak was also shifted to a significant lower temperature (56,9 
ºC). The decreased Tm found for PEO is an indication of thinner crystalline lamellae 
which might be the result of PLLA templating effect, as shown by Rufino et al.124 
Moreover, significant reduction on both PLLA and PEO melting enthalpies suggests 
some miscibility degree between PLLA and PEO due to crystallization restriction 
imposed by one phase on the other. Finally, the increased PLLA Tm indicates 
increased lamellae thickness and might also be the result of miscibility.  
 
Table 5. Thermal properties of PLLA, PEO and PLLA/PEO blends.  
Thermal event PEO PLLA PLLA/PEO 
Tg/ºC 
First heating Unnoticeable 56.9 Unnoticeable 
Second heating -50.1 39.5 
-20.5 
-29.8 
Tc /ºC 
First heating - - - 
Cooling 39.2 - 69.5** 
Second heating - 95.6 - 
ΔHc/J g
-1 
First heating - - - 
Cooling 130.9 - 21.3** 
Second heating - 18.9 - 
Tm/ºC 
First heating 74.6 121 
128.6* 
61.3** 
Second heating 70.4 111.3 and 123.9 
125.8* 
56.9** 
ΔHm/J g
-1 
First heating 181.1 Undefined 
30.2* 
33.8** 
Second heating 137.7 20.3 
19.6* 
27.1** 
Values corresponding to *PLLA and ** PEO in the blends. 
 
It is interesting to notice the change of the bimodal melting of pure PLLA to 
the almost monomodal melting of the PLLA in the blend, which suggests that the 
presence of PEO changes the preferential PLLA crystalline phase. However, the 
PLLA affects much more the PEO crystallinity of the other polymer because as seen 
in the large Tm depression, especially in the first heating. In conclusion, the shifts of 
Tm and Tm depressions indicate partial miscibility between PLLA and PEO.  
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Similar Tm shifts have been reported for PLLA/PEO blends with high 
molecular weight PLLA. Usually it is verified that larger Tm drops are exhibited for the 
lower molecular weight polymer or the one in the lowest concentration.115,117 
Therefore, it is possible to conclude that in this work the blend film consists of two 
semi-miscible polymers with distinct crystalline phases dispersed in a miscible 
amorphous matrix. In fact, the most accurate influence of PEO was observed in the 
blend coating related to the PLLA degradation therefore the NO release, which are 
discussed latter,  
 
SNAP-doped coatings were obtained by spin coating using PLLA/PEO 
solution for the blend described above. Visually, the coating obtained was similar to 
the monolayer and bilayer samples PLLA-SNAP. The ATR-IR spectra of SNAP-
doped blend coatings are shown in Fig.27. The main characteristic peaks of PLLA 
appear again in the coating. The spectrum of the PLLA/PEO-SNAP 10 coating 
depicts the characteristic bands of PEO around at 3500 cm−1 for ν(OH), 2885 cm−1, 
νas(CH) of CH2, 1455 cm
−1 of CH2 scissoring, 1345 cm
−1 of δab(CH2 ), 1078 cm
−1 for 
ν(C-O),156,157 confirming the deposition of the polymer onto the PP substrate. The 
peak assigned to the N=O stretching vibration is unnoticed, indicating that SNAP is 
not exposed at the surface or is present at the concentration not enough to be 
detected by reflectance IR spectroscopy. One may consider that the presence of 
PEO increases the amorphous PLLA phase resulting in an increased of SNAP 
solubility and its depletion from the surface. 
 
Fig. 27. Vibrational spectra of SNAP-doped PLLA/PEO-SNAP 10: red arrows show 
the main peaks of PEO in the blend. The dashed rectangles depict the mean peaks 
of PLLA shown in Fig.19a. 
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Fig.28 shows micrographs of PLLA/PEO-SNAP 10. The observed 
morphology is similar to that observed for the PLLA-SNAP coatings, with the 
presence of larger cavities. However, needle-like crystals are seen inside a close to 
the borders of cavities, which may be assigned to SNAP segregation during solvent 
evaporation. This segregation may be due to a decrease SNAP solubility in the PEO 
matrix. Further experiments are necessary to confirm this hypothesis.  
 
  
 
Fig. 28. SEM micrographs of a SNAP-doped monolayer of PLLA/PEO-SNAP 10 (a) 
with magnification of the yellow square of (a) (b)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) (a) 
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4.3. Kinetics of NO release from PLLA-SNAP and PLLA/PEO-SNAP coatings 
 
As aforementioned, the decomposition of RSNOs comprehends several 
pathways. Thermal (Δ) and photochemical (hv) decomposition take place through the 
homolytic cleavage of the S–NO bond, the simplest and lowest energy pathway 
(Eq.17 to 19), releasing NO and yielding the dimer RS–SR (disulphide). According to 
the initial step, there is a homolytic cleavage of the S-N bond to give NO and thiyl 
radicals (RS•), followed by the reaction between the RS• formed with a second 
RSNO molecule, leading to the formation of a sulfur bridge with simultaneous release 
of a second NO molecule (Eq.18). Eq.19 shows the possible bimolecular reaction 
between two thiyl radicals to yield a disulfide product. However, a bimolecular 
reaction between two reactive species present at low concentrations is unlikely. For 
this reason, the formation of the disulphide species is more likely to involve the 
reaction between a thiyl radical and an intact RSNO molecule, which is present at a 
higher concentration.43,158,159  
 
                                                   (17) 
                                                        (18) 
                                                         (19) 
 
This set of reactions, for the case of SNAP occurs in the aqueous medium. 
Therefore, SNAP stability within the polymeric matrix and its sustained lixiviation by 
diffusion or polymeric degradation are factors that contribute to the NO release in a 
sustainable fashion. For instance, due to the hydrophobic character of SNAP, this 
molecule tends to remain in the more hydrophobic polymer matrix, which is stabilized 
by intermolecular hydrogen bonding between crystallized molecules. 59,77 Related to 
that factors and based on the NO release obtained from PLLA-SNAP and 
PLLA/PEO-SNAP coatings, the mechanism of NO release from the SNAP leached in 
aqueous media (physiological conditions) will be purposed and discussed latter, for 
its greater understanding. 
 
Firstly, in order to obtain the release rate of the total amount of SNAP 
contained in the volume of polymeric solution used to coat the PP films, the NO 
release rate from dissolved SNAP was analyzed under physiological conditions. A 
solution of SNAP 9 mM containing 100 µM EDTA was prepared considering the poor 
SNAP solubility in water (2 mg mL-1), 333 µL (300 nmol) of this solution were added 
into the NOA sample vessel containing PBS with 100 µM EDTA at 37 ºC, protected 
from light. The real time release was measured for 1 h. This control experiment was 
hv  
Δ 
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conducted in triplicate. The NO release profile from dissolved SNAP is depicted in the 
Fig.29, showing an initial burst at the first minute of measurement, followed by a 
plateau with a NO releasing rate of 1.0 ± 0.2 nmol min-1. The cumulative NO release 
before 1 h of analysis was 64 ± 9 nmol, corresponding to 21 % of the total molar 
amount of SNAP added. 
  
 
Fig. 29(a) Real time NO release from aqueous SNAP and (b) cumulative NO release, 
obtained from the integration of the curve in (a). The curves were obtained after the 
injection of 333 µL of SNAP 9 mM in 10 mL PBS containing 100 µM of EDTA at 37 ºC, 
protected from light. The shaded area corresponds to the SD of triplicates.  
 
Fig.30 shows the real time NO release profiles of PLLA-SNAP 10, PLLA-
SNAP 20, PLLA-SNAP/PLLA-SNAP 10, and PLLA/PEO-SNAP 10 samples. The 
monitoring was carried out during 1h. The initial rates of NO release (Ir) were 
calculated from the slopes of the curves after 5 min of measurement, during which a 
short burst release is observed in all cases. This short burst release can be assigned 
to the elution of the fraction of SNAP molecules which are more exposed a loosely 
bound on the surface. The Ir of PLLA-SNAP 10 and PLLA-SNAP 20 monolayers were 
11 ± 1 pmol cm-2 min-1 and 23 ± 3 pmol cm-2 min-1, respectively. This difference is 
considered to be statistically significant (Fig.30a and b). Therefore, doubling the 
SNAP concentration led to a 2-fold higher Ir as well as a 2-fold higher cumulative NO 
released after 1 h, suggesting that the distribution of SNAP in the PLLA matrix is 
homogeneous and the amount of SNAP exposed at the surface (which elutes in the 1 
h period) is directly proportional to the SNAP concentration.  
 
The real time NO release profile of the PLLA-SNAP/PLLA-SNAP 10 is 
shown in Fig.30c. The Ir obtained was 11
 ± 2 pmol cm-2 min-1 which is statistically 
(a) (b) 
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equal to the Ir monolayer (11
 ± 1 pmol cm-2 min-1). Therefore, a second layer did not 
increase the Ir indicating that NO release occurs only at the outermost surface of the 
coating. This result supports the proposal of using PLLA-SNAP coatings for 
sustained NO release.  
  
  
 
Fig. 30. Real time NO release profiles of (a) PLLA-SNAP 10, (b), PLLA-SNAP 20, (c) 
PLLA-SNAP/PLLA-SNAP 10 and (d) PLLA/PEO-SNAP 10. NO release 
measurements were carried out in PBS at 37 ºC protected from light. The shaded 
area corresponds to the SD of triplicates. 
 
In the case PLLA/PLLA-SNAP (second monolayer of PLLA), the real time 
NO release did not show significant release during 1 h, since the NO release was 
below the detection limit of the method (data not shown). This result indicates that a 
PLLA topcoat acts as a protective coating and is capable of blocking NO release from 
the underneath PLLA-SNAP coating during a short term exposition to the aqueous 
medium. Finally, Fig.30d shows the real time NO release profile of the PLLA/PEO-
(a) (b) 
(c) (d) 
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SNAP 10. The Ir obtained was 10 ± 4 pmol cm
-2 min-1 which is statistically equal to 
the Ir obtained for the PLLA-SNAP 10. Therefore, the presence of PEO does not 
change the kinetics of NO release suggesting that SNAP is exclusively dissolved in 
the PLLA matrix. 
  
The rate of real time NO release obtained for aqueous SNAP solution and 
for SNAP incorporated in the PLLA and PLLA/PEO matrices are shown in Fig.31 and 
table 6, in comparison with the rates of endogenous NO production by the surface of 
endothelial cells lining blood vessels, as well as the rates of NO release necessary 
for inhibiting platelet adhesion and thrombus formation and bacterial adhesion.36,68,77 
It can be seen that the rates of NO release of 6 - 20 pmol cm-2 min-1obtained are 
lower than the rate displayed by healthy endothelial cells from the inner walls of the 
blood stream.68,77  On the other hand, they are higher than the required flux to inhibit 
the bacterial adhesion and to prevent thrombus formation;36 These values suggest 
that SNAP-doped polymeric coatings have potential to be employed as contacting 
blood biomaterial and blood–contacting biomaterials. In comparison with NO fluxes 
reported for SNAP-doped CarboSil® based coatings, 50 – 550 nmol cm-2 min-1,59,68,77 
the values obtained in the present study are lower showing that PLLA degradation 
can be used as tool to modulate the rate of NO release from SNAP.  
 
 
Fig. 31. Comparison of the NO release rates from different coatings obtained from 
the NO release profiles during 1h in PBS at 37 ºC protected from light with the 
endogenous NO release rates provided by the surface of endothelial cells and the 
NO release rates necessary for inhibiting thrombus formation and bacterial 
adhesion.36,68,77 PLLA/PLLA-SNAP 10sample did not show significant NO release. (*) 
p ˂ 0.001. (**) p ˂ 0.02.  
Endogenous NO production 
Inhibition of bacterial adhesion 
Inhibition of thrombus formation 
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Table 6. t-test for statistical significance evaluation (p values) for of NO release rates. 
Coating 
Initial rate ± SD /pmol 
cm-2 min-1 
Free SNAP PLLA-SNAP 10 
Free SNAP 1.0 ± 0,2a - - 
PLLA-SNAP 10 11 ± 1 0.0010 - 
PLLA-SNAP/PLLA-SNAP 10 11 ± 2 0.0010 1 
PLLA-SNAP 20 23 ± 3 0.0011 0.0028 
PLLA/PEO-SNAP 10 10 ± 4 0.0010 0.6960 
a Units for NO release rate of SNAP in PBS are nmol min-1.   
 
Fig.32 shows the schematic illustration of the NO release mechanism 
proposed for SNAP-doped coatings base on the NO release mechanism described 
by Yaqi Wo., et al.  
 
Fig 32. Schematic illustration of the NO release from the PLLA-SNAP coatings after 
their immersion in water or physiological medium (PBS at 37 ºC). Green 
parallelepipeds represent SNAP molecules, which are released from the polymeric 
matrix as the PLLA degradation takes place. Two NO molecules are released when 
the disulphide dimer is formed. 
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The SNAP molecules most exposed to the aqueous solution at 
physiological conditions dissolve and diffuse in the aqueous medium at the 
solid/liquid interface. Once in solution, collisions between two SNAP molecules or 
between pre-formed thiyl radical and an intact SNAP molecule leads to free NO 
release according to Eqs.17 and 19. After this phase the slow degradation of PLLA at 
physiological conditions is expected to control the dissolution and decomposition of 
SNAP molecules which are beneath the surface, leading to slow NO release phase, 
controlled by the rate of PLLA hydrolysis.  
 
4.4. Quantification of short-term NO release 
 
The reaction of a RSNO with a nucleophile such as ascorbic acid is 
another decomposition pathway, in which NO acts as a leaving group due to the 
strongly polarized S–N bond. This reaction depends on both ascorbate concentration 
and solution pH. Under certain pH, the acid may be in the protonated or 
deprotonated form.158 Under the accelerated conditions used herein, ascorbate di-
anion stoichiometrically reacts with SNAP releasing NO, and can be used to calculate 
the SNAP dose. 
 
The initial SNAP doses in the coatings measured by the ascorbate method 
were proportional, to the SNAP charges used in the PLLA matrix, and raged from 14 
± 1 nmol cm-2 to 31 ± 7 nmol cm-2. It must be noted however that these doses 
correspond to the amount of SNAP close to the surface which was accessed by the 
reducing ascorbate anion, and do not represent the total SNAP content of the 
samples. These values reflect the NO release from the superficial SNAP, which the 
fraction of SNAP molecules most exposed a loosely bound on the surface. 
 
4.5. Long-term NO release from PLLA-SNAP and blended PLLA/PEO coatings 
 
Long-term monitoring of the NO release process from the coatings 
immerged in PBS at 37 ºC as carried out by quantifying the total NO released and 
accumulated over time in a vial containing the samples. In this case, the NO release 
could depended on the hydrolytic degradation of PLLA, which takes place by chain 
scission, leading to decreased polymer Mw.
760 This chemical reaction depends on pH, 
temperature and the length of the chains.160 The mechanism proposed comprehends 
the polymer degradation followed by SNAP leaching to the aqueous media and, 
ultimately NO release. NO is expected to be easily oxidized to nitrite and nitrate by 
dissolved oxygen in the PBS medium as shown in Eq.4.19 The cumulative value, was 
measured using the VCl3 reduction method which reduces nitrite and nitrate back to 
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free NO (Eq.14). This implies that the released NO does not exceed PBS solubility 
limit and therefore does not evolve from the aqueous medium.  
 
Fig.33 depicts the kinetic curves of NO release assembling data from 
different samples under different conditions. The long-term NO releasing assays 
comprehend three stages beginning with the physiological condition (PBS at 37 ºC), 
followed by the raise of temperature and finishing with the raise of pH.  
 
Considering the real time NO release rate (Ir obtained before), of 11 pmol 
cm-2 min-1 after 7 h of incubation in PBS at 37 ºC, the PLLA-SNAP 10 monolayer and 
bilayer samples are expected values of cumulative NO dose of 5 nmol cm-2 for both 
since the Ir are the same, while in Fig.33a, the initial NO release values after 7h were 
about the same order of magnitude 20 nmol cm-2. The same trend can be observed 
in the Fig.33b for the PLLA-SNAP 20 monolayer and bilayer. Considering the real 
time NO release rate of 23 pmol cm-2 min-1 (Ir obtained before), the expected dose of 
NO released after 7 h is 10 nmol cm-2 for both samples, while in Fig.33b the initial NO 
release values after 7 h were around 60 nmol cm-2.  
  
Fig. 33. Cumulative NO release under physiological (black squares and circles) and 
accelerated conditions (colored squares and circles) from (a) PLLA-SNAP 10 
monolayer (square) and bilayer (circle) and (b) PLLA-SNAP 20 monolayer (square) 
and bilayer (circle). Data mean ± SD (n = 3). 
 
Since after 8 days at 37 °C the cumulative NO released reached a plateau 
(Fig.33a and b), further measurements were taken under accelerated hydrolysis 
conditions at pH 8.8.67 The total NO release from monolayer samples of SNAP 10 wt% 
(a) (b) 
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and 20 wt% were 28.7 ± 0.2 nmol cm-2 and 67.0 ± 0.2 nmol cm-2, reaching complete 
NO release after 30 days.  
 
Using bilayer coatings, NO release was prolonged for 13 days under 
accelerated conditions, 37 °C and pH = 9, reaching a total NO release of 21.7 ± 0.1 
nmol cm-2 and 67.3 ± 0.5 nmol cm-2, respectively, in both cases, the monolayer 
cumulative NO profiles were slightly higher than the bilayer cumulative NO profiles 
(Fig.33a and b) due probably to the fluctuation in the experimental data inherent to 
this protocol. 
 
A comparison between the expected values of cumulative NO release of 5 
and 10 nmol cm-2 (before 7 h, for both SNAP concentration) and values of SNAP 
quantification of 14 and 31 nmol cm-2 (short-term measurements, for both 
concentration), are values lower than the initial cumulative obtained, which were 20 
and 60 nmol cm-2. These differences allow us to conclude that the initial NO release 
is governed by the superficial SNAP and as this superficial SNAP is released, the NO 
release is now governed by the PLLA degradation (more than 7 h), which exposes 
the SNAP to the surface and the SNAP decomposition happens (Fig.32). The other 
conclusion is that under prolonged hydrolytic conditions PLLA hydrolysis lead to 
higher amounts of NO release. 
 
Samples with the second coating of neat PLLA showed the same trend 
(Fig.34). Initial values of the NO release from PLLA/PLLA-SNAP 10 and PLLA/PLLA-
SNAP 20 samples were in the same order of magnitude of 0.7 ± 0.2 nmol cm-2 and 1 
± 0.4 nmol cm-2, after 8 hours, respectively. The total NO released were 2.54 ± 0.04 
nmol cm-2 and 3.2 ± 0.2 nmol cm-2, respectively. NO release was verified up to 40 
days in both cases under accelerated conditions (increasing temperature and pH). 
Therefore, a PLLA topcoat decreases substantially the NO release in comparison 
with other coatings, due to PLLA topcoat protecting effect.  
 
Additionally, the long-term NO release from the immersion of PLLA/PEO-
SNAP 10 took 32 days in PBS at 37 ºC (Fig.35). The initial NO release value was 75 
± 3 nmol cm-2 after 6 h; PLLA/PEO-SNAP 10 led to a 3-fold increase in the initial NO 
release relative to PLLA-SNAP 10. After 32 days the total NO released was 95.8 ± 
0.6 nmol cm-2. This result indicates that by blending PLLA with PEO, the NO release 
can be modulated leading to a significant increase in the total NO release. 
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Fig. 34. Cumulative NO release under physiological and accelerated conditions of 
PLLA/PLLA-SNAP 10(squarer) and PLLA/PLLA-SNAP 20(circle).  Data mean ± SD 
(n = 3). 
 
Fig. 35. Cumulative NO release under physiological of PLLA/PEO-SNAP 10. Data 
mean ± SD (n = 3). 
 
It is interesting to notice that the presence of PEO in the coating, 
PLLA/PEO samples, increased the hydrophilicity if the material compared with PLLA 
only (p ˂ 0.003), as shown by the contact angle measurements (Fig.36). This higher 
wettability may contribute to a faster hydrolytic degradation process, corroborating 
the higher cumulative NO release observed for the PLLA/PEO-SNAP samples. On 
the other hand, the hydrophilicity was not affected by the presence of SNAP. 
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PLLA coat PLLA-SNAP 10 
  
65 ± 2° 61 ± 4° 
PLLA/PEO-SNAP 10 Bare PP substrate 
  
51 ± 3° 84.9 ± 0.1° 
 
Fig. 36. Contact angle measurements on PLLA coat, PLLA-SNAP 10, PLLA/PEO-
SNAP 10 coatings onto PP substrate and bare PP substrate samples. 
 
Fig.37 shows the sulfur element mapping of the PLLA-SNAP 10 sample, 
which allows inferring the SNAP distribution within the coating is homogeneous. 
Fig.38 shows the EDS spectra obtained during the hydrolysis assay. It can be seen 
that the peak assigned to sulfur disappears after hydrolyzes, suggesting that the 
SNAP located in the surface was leached out. 
 
 
 
Fig. 37 Sulfur element mapping of PLLA-SNAP 10 before hydrolysis in PBS at 37 ºC. 
(a) (b) 
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Fig. 38 Smoothed spectrum of long-term hydrolysis of PLLA-SNAP 10 before 
immersion (0 d), after 15 d and 30 d after immersion in PBS at 37 ºC. 
 
The morphological changes due to the hydrolysis in PBS at 37 ºC are 
shown in Fig. 39. The micrographs of hydrolyzed PLLA-SNAP monolayer displayed 
an erosion process of the polymeric coating, resulting in the formation of fissures that 
grew as the hydrolysis proceeded (Fig.39a). For bilayer coatings (Fig.39b and c), the 
polymeric erosion is more evident; since the cracks and fissures in the region 
between pores grew.  
 
In the case of PLLA-SNAP/PLLA-SNAP 10, it is possible to distinguish that 
the topcoat suffered degradation, resulting in pore formation after 15 days. After 30 
days the inner region of the pores presented no changes. In contrast, in PLLA/PLLA-
SNAP 10the inner coating is visible and the topcoat is hydrolyzed; the size of the 
initial cavities increased and fissures appeared. The morphology of the inner coating 
resembles the morphology of a monolayer coating. After 30 days the inner and 
topcoat cannot be distinguished, suggesting that the inner coating began to 
hydrolyze as well. For blended coating (Fig.39d), the decreasing of number of pores 
and the increasing of pore size generated by the degradation process from 15 days 
until 30 days might be observed. The inner region of the pores in both coatings 
seems to hydrolyze as well, these regions appear deeper. Additionally, micrographs 
of hydrolysis blended coatings indicate no phase segregation of the polymer 
constituents of the blend. 
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Fig. 39. SEM micrographs of in vitro hydrolysis for before immersion (left), after 15 
days (middle) and 30 days (right) of immersion in PBS at 37 ºC of (a) PLLA-SNAP 10, 
(b) PLLA-SNAP/PLLA-SNAP 10, (c) PLLA/PLLA-SNAP 10 and (d) PLLA/PEO-SNAP 
10. 
 
 
 
 
 
 
(a) 
(b) 
(c) 
(d) 
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5. CONCLUSIONS AND PERSPECTIVES 
 
Homogeneous and PLLA-SNAP coatings can be obtained on the surface 
of polypropylene by the spin coating. 
PLLA-SNAP coatings are able to modulate the rate and dose of NO 
release to aqueous environments. 
PLLA-SNAP coatings are able to release NO during prolonged times in a 
process governed by the slow hydrolysis of the PLLA matrix. 
The rates of NO release from PLA/SNAP coatings can be adjusted to 
levels with potential to inhibit bacterial adhesion and thrombus formation in blood 
contacting medical devices. 
PLLA/PEO-SNAP coatings showed faster hydrolytic degradation process 
obtaining higher cumulative NO release values.  
As futures perspectives, firstly, NO release profiles could be obtained for 
longer times and for the different PLLA/PEO compositions. The store stability of the 
PLLA-SNAP and PLLA/PEO-SNAP coatings could be evaluated. Secondly, NO 
release profiles for some medical devices coated with PLLA-SNAP by dip coating 
could be evaluated. Finally, biological assays could be performed in order to evaluate 
the potential biological activity of the PLLA-SNAP coatings in inhibiting platelet, 
bacterial adhesion and tissue regeneration as well as evaluate the cytotoxicity of the 
coatings. 
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SUPPLEMENTARY MATERIAL 
 
Calibration curve for nitrite determination 
 
The NO is detected by the NOA equipment as mV units. Using a 
calibration curve the mV signal is converted to NO flux as mol min-1 units. The 
calibration curve is obtained adding known aliquots of NaNO2 20 µM in triplicate. 
According to Eq.S-1, the nitrite ion is quantitatively reduced to NO by the iodide ion, 
which is in excess in the 0.1 M acetic acid solution (NaI 0.1 M) 
 
            
                                         S-1 
 
The calibration curve is performed at 37 °C, the sample vessel contains 10 
mL of reducing agent in acid solution. Aliquots of 20, 40, 60, 80 and 100 µL of NaNO2 
20 µM are added in sequence and a figure is obtained in function of time (Fig.S-1a). 
The NO amount added in each aliquot is proportional to the area (mV min) of the 
peak, which is known by the integration of the respective peak. Afterwards, the area 
values are plotted against the known NO nmol as Fig.S-1b shows. Finally, a linear fit 
is realized in order to obtain the equation that defines the line. 
 
  
 
Fig. S-1(a). Representative graphic obtained by the aliquots addition in triplicate (20, 
40, 60, 80 and 100 µL of NaNO2), the added NO nmol are indicated above each set 
of peaks. (b) Calibration curve is by the peak integration of (a) and its equation is 
obtained by the linear regression of the mean ± SD.  
 
 
(a) (b) 
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Calibration curve for nitrate determination (vanadium (III) chloride 
method) 
 
In this method the NO is detected by the NOA equipment as mV units as 
the current measurements. According to Eq.B-1,VCl3 in hydrochloric acid (saturated 
solution) reduces nitrite species to nitric oxide. Using a calibration curve the mV 
signal is converted to NO flux as mol min-1 units. The calibration curve is obtained 
adding known aliquots of NaNO3 20 µM in triplicate.  
 
          
               
                        B-1 
 
The calibration curve is performed at 85 °C, the sample vessel contains 10 
mL of reducing agent in acid solution. Aliquots of 20, 40, 60, 80 and 100 µL of NaNO3 
20 µM are added in sequence and a figure is obtained in function of time (Fig.S-2a). 
The NO amount added in each aliquot is proportional to the area (mV min) of the 
peak, which is known by the integration of the respective peak. Afterwards, the area 
values are plotted against the known NO nmol as Fig.S-2b shows. Finally, a linear fit 
is realized in order to obtain the equation that defines the line.  
 
  
 
Fig. S-2(a). Representative graphic obtained by the aliquots addition in triplicate (20, 
40, 60, 80 and 100 µL of NaNO2), the added NO nmol are indicated above each set 
of peaks. (b) Calibration curve is by the peak integration of (a) and its equation is 
obtained by the linear regression of the mean ± SD. 
 
 
 
 
 
(a) (b) 
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Thermal history of PLLA 
 
 
Fig. S-3. Thermogram of PLLA by DSC showing the thermal history (first heating and 
cooling cycle, with 10 °C min-1) displaying the temperatures related to the thermal 
events, the glass transition temperature at 56,9 °C and the melting temperature at 
121 °C. The dashed line indicates the absence of the first melting temperature, 
instead of there is undefined peak in the multiple melting peaks depicted as a result 
of the PLLA polymorphism, whereas during cooling no crystallization peaks are 
obtained since the crystallization kinetics from the melt is slow and cannot be 
perceptible.  
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SEM micrograph of polypropylene substrate 
 
 
 
Fig. S-4. SEM micrograph of bare PP substrate allowed evaluating the surface 
morphology. The PP surface display crystalline sites along the PP sheet supporting 
the diffraction pattern of the PP which suggested a crystalline structure. In 
comparison with PP coated, the coatings showed different morphologies with or 
without cavities observed along the surface. 
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Thermal history of PEO 
 
 
 
 
Fig. S-5. Thermogram of PEO by DSC showing the thermal history (a) first heating 
cycle the Tg could not be observed; Possibly, the amorphous phase volumetric 
fraction decreasing as a result of the high crystallinity degree. Additionally, a large 
sharp endothermic peak is observed at 74.6 °C related to Tm. (b) In the cooling cycle 
the crystallization is depicted at 39 °by intense exothermic peak. The enthalpy values 
are shown in each figures and the glass transition temperature, the melting 
temperature and the crystallization temperature are summarized in Table.5. 
 
(a) 
(b) 
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Thermal history of PLLA/PEO 70:30 
 
 
 
 
Fig. S-6. Thermogram of PLLA/PEO 70:30 by DSC showing the thermal history (a) 
first heating cycle the Tg could not be observed due to its overlap with PEO melting 
peak as well as the PLLA Tg. Additionally, both Tm suffered a reduction of intensity 
and a shift, as well as significant reduction on both PLLA and PEO melting enthalpies. 
(b) In the cooling cycle the crystallization is depicted at 69.5 °C by weak exothermic 
peak, suffered a reduction of intensity and a shift. The irregular peak about 0 to 25 °C 
could indicate presence of water in the blend. These thermal events values might 
indicate blend miscibility as aforementioned and are summarized in Table.5. 
(a) 
(b) 
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